Quiver News

The latest insights and financial news from Quiver Quantitative

+ News Alerts
All News Breaking News Summary Contracts Congress Trades Funds Government Insiders Legislation Lobbying Press Releases External
$CLOV stock is down 8% today. Here's what we see in our data.
13 minutes ago | April 1, 2026 2:57 p.m. UTC

$CLOV stock has now fallen 8% today, according to our price data from Polygon. There has been approximately $7,027,521 of trading volume.

It has been the 200th most-searched ticker on Quiver Quantitative over the last day, out of 11,571 total tickers searched.

Here is what we see in our data on $CLOV (you can track the company live on Quiver's $CLOV stock page):

$CLOV Insider Trading Activity

CLOV Insider Trades

$CLOV insiders have traded $CLOV stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $CLOV stock by insiders over the last 6 months:

  • BRADY PATRICK PRIEST (CEO of Home Care) sold 175,000 shares for an estimated $379,750
  • JAMIE L. REYNOSO (CEO, Medicare Advantage) has made 0 purchases and 7 sales selling 66,356 shares for an estimated $199,675.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CLOV Hedge Fund Activity

We have seen 80 institutional investors add shares of $CLOV stock to their portfolio, and 95 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CLOV Analyst Ratings

Wall Street analysts have issued reports on $CLOV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Canaccord Genuity issued a "Buy" rating on 11/06/2025

To track analyst ratings and price targets for $CLOV, check out Quiver Quantitative's $CLOV forecast page.

$CLOV Price Targets

Multiple analysts have issued price targets for $CLOV recently. We have seen 2 analysts offer price targets for $CLOV in the last 6 months, with a median target of $2.85.

Here are some recent targets:

  • Richard Close from Canaccord Genuity set a target price of $3.2 on 03/20/2026
  • Whit Mayo from Leerink Partners set a target price of $2.5 on 03/05/2026

You can track data on $CLOV on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article
$IBRX stock is down 4% today. Here's what we see in our data.
13 minutes ago | April 1, 2026 2:57 p.m. UTC

$IBRX stock has now fallen 4% today, according to our price data from Polygon. There has been approximately $42,472,746 of trading volume.

It has been the 135th most-searched ticker on Quiver Quantitative over the last day, out of 11,571 total tickers searched.

Here is what we see in our data on $IBRX (you can track the company live on Quiver's $IBRX stock page):

$IBRX Insider Trading Activity

IBRX Insider Trades

$IBRX insiders have traded $IBRX stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $IBRX stock by insiders over the last 6 months:

  • BARRY J. SIMON has made 0 purchases and 5 sales selling 401,967 shares for an estimated $3,778,685.
  • CHRISTOBEL SELECKY has made 0 purchases and 3 sales selling 100,000 shares for an estimated $687,650.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$IBRX Hedge Fund Activity

We have seen 130 institutional investors add shares of $IBRX stock to their portfolio, and 92 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • HEIGHTS CAPITAL MANAGEMENT, INC removed 6,565,709 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $13,000,103
  • BLACKROCK, INC. added 5,790,256 shares (+29.2%) to their portfolio in Q4 2025, for an estimated $11,464,706
  • STATE STREET CORP added 5,139,890 shares (+45.4%) to their portfolio in Q4 2025, for an estimated $10,176,982
  • VANGUARD GROUP INC added 5,122,052 shares (+18.5%) to their portfolio in Q4 2025, for an estimated $10,141,662
  • CITIGROUP INC removed 2,271,488 shares (-95.4%) from their portfolio in Q4 2025, for an estimated $4,497,546
  • TWO SIGMA INVESTMENTS, LP added 2,109,983 shares (+80.9%) to their portfolio in Q4 2025, for an estimated $4,177,766
  • WOODLINE PARTNERS LP removed 1,851,185 shares (-34.9%) from their portfolio in Q4 2025, for an estimated $3,665,346

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$IBRX Analyst Ratings

Wall Street analysts have issued reports on $IBRX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • HC Wainwright & Co. issued a "Buy" rating on 02/23/2026
  • Piper Sandler issued a "Overweight" rating on 01/20/2026
  • D. Boral Capital issued a "Buy" rating on 01/20/2026

To track analyst ratings and price targets for $IBRX, check out Quiver Quantitative's $IBRX forecast page.

$IBRX Price Targets

Multiple analysts have issued price targets for $IBRX recently. We have seen 7 analysts offer price targets for $IBRX in the last 6 months, with a median target of $12.0.

Here are some recent targets:

  • Jason Kolbert from D. Boral Capital set a target price of $23.0 on 03/26/2026
  • Jeet Mukherjee from BTIG set a target price of $13.0 on 03/12/2026
  • Edward Tenthoff from Piper Sandler set a target price of $12.0 on 03/04/2026
  • Andres Y. Maldonado from HC Wainwright & Co. set a target price of $15.0 on 02/23/2026
  • Kelly Shi from Jefferies set a target price of $9.0 on 12/12/2025

You can track data on $IBRX on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article
$TPB stock is down 18% today. Here's what we see in our data.
13 minutes ago | April 1, 2026 2:57 p.m. UTC

$TPB stock has now fallen 18% today, according to our price data from Polygon. There has been approximately $48,507,901 of trading volume.

Here is what we see in our data on $TPB (you can track the company live on Quiver's $TPB stock page):

$TPB Insider Trading Activity

TPB Insider Trades

$TPB insiders have traded $TPB stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.

Here’s a breakdown of recent trading of $TPB stock by insiders over the last 6 months:

  • LAWRENCE WEXLER has made 0 purchases and 3 sales selling 46,470 shares for an estimated $4,635,682.
  • DAVID EDWARD GLAZEK (Executive Chairman) sold 30,000 shares for an estimated $3,307,800
  • BRITTANI CUSHMAN (Sr VP, General Counsel) has made 0 purchases and 5 sales selling 15,250 shares for an estimated $1,550,315.
  • H.C. CHARLES DIAO sold 2,000 shares for an estimated $216,400
  • STEPHEN USHER has made 0 purchases and 2 sales selling 2,000 shares for an estimated $203,540.
  • ANDREW FLYNN (Chief Financial Officer) sold 2,000 shares for an estimated $195,140
  • GREGORY H.A. BAXTER sold 1,500 shares for an estimated $147,345

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$TPB Hedge Fund Activity

We have seen 128 institutional investors add shares of $TPB stock to their portfolio, and 107 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$TPB Analyst Ratings

Wall Street analysts have issued reports on $TPB in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Oppenheimer issued a "Outperform" rating on 11/19/2025
  • Alliance Global Partners issued a "Buy" rating on 11/06/2025

To track analyst ratings and price targets for $TPB, check out Quiver Quantitative's $TPB forecast page.

$TPB Price Targets

Multiple analysts have issued price targets for $TPB recently. We have seen 2 analysts offer price targets for $TPB in the last 6 months, with a median target of $115.0.

Here are some recent targets:

  • Ian Zaffino from Oppenheimer set a target price of $120.0 on 11/19/2025
  • Aaron Grey from Alliance Global Partners set a target price of $110.0 on 11/06/2025

You can track data on $TPB on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article
$COGT stock is down 8% today. Here's what we see in our data.
13 minutes ago | April 1, 2026 2:57 p.m. UTC

$COGT stock has now fallen 8% today, according to our price data from Polygon. There has been approximately $98,128,070 of trading volume.

It has been the 751st most-searched ticker on Quiver Quantitative over the last day, out of 11,571 total tickers searched.

Here is what we see in our data on $COGT (you can track the company live on Quiver's $COGT stock page):

$COGT Insider Trading Activity

COGT Insider Trades

$COGT insiders have traded $COGT stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $COGT stock by insiders over the last 6 months:

  • FUNDS MANAGEMENT LLC FAIRMOUNT has made 0 purchases and 2 sales selling 10,500,000 shares for an estimated $370,020,000.
  • JOHN EDWARD ROBINSON (Chief Scientific Officer) sold 90,000 shares for an estimated $3,486,600
  • JESSICA SACHS (Chief Medical Officer) sold 82,642 shares for an estimated $3,198,245
  • JOHN L. GREEN (Chief Financial Officer) sold 77,000 shares for an estimated $2,978,360
  • EVAN KEARNS (Chief Legal Officer) sold 65,000 shares for an estimated $2,515,500

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$COGT Hedge Fund Activity

We have seen 171 institutional investors add shares of $COGT stock to their portfolio, and 86 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$COGT Analyst Ratings

Wall Street analysts have issued reports on $COGT in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Wedbush issued a "Outperform" rating on 01/21/2026
  • HC Wainwright & Co. issued a "Buy" rating on 01/06/2026
  • JP Morgan issued a "Overweight" rating on 12/19/2025
  • Leerink Partners issued a "Outperform" rating on 11/10/2025

To track analyst ratings and price targets for $COGT, check out Quiver Quantitative's $COGT forecast page.

$COGT Price Targets

Multiple analysts have issued price targets for $COGT recently. We have seen 8 analysts offer price targets for $COGT in the last 6 months, with a median target of $52.0.

Here are some recent targets:

  • David Nierengarten from Wedbush set a target price of $55.0 on 03/17/2026
  • Faisal Khurshid from Jefferies set a target price of $55.0 on 03/16/2026
  • Christopher Raymond from Piper Sandler set a target price of $52.0 on 02/18/2026
  • Robert Burns from HC Wainwright & Co. set a target price of $52.0 on 01/06/2026
  • Anupam Rama from JP Morgan set a target price of $67.0 on 12/19/2025
  • Colleen Kusy from Baird set a target price of $34.0 on 11/11/2025
  • Andrew Berens from Leerink Partners set a target price of $50.0 on 11/10/2025

You can track data on $COGT on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article
$MLTX stock is down 10% today. Here's what we see in our data.
13 minutes ago | April 1, 2026 2:57 p.m. UTC

$MLTX stock has now fallen 10% today, according to our price data from Polygon. There has been approximately $30,456,602 of trading volume.

It has been the 463rd most-searched ticker on Quiver Quantitative over the last day, out of 11,571 total tickers searched.

Here is what we see in our data on $MLTX (you can track the company live on Quiver's $MLTX stock page):

$MLTX Insider Trading Activity

MLTX Insider Trades

$MLTX insiders have traded $MLTX stock on the open market 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $MLTX stock by insiders over the last 6 months:

  • KRISTIAN REICH (Chief Scientific Officer) has made 0 purchases and 2 sales selling 202,908 shares for an estimated $3,012,462.
  • DA SILVA JORGE SANTOS (Chief Executive Officer) has made 0 purchases and 2 sales selling 200,000 shares for an estimated $2,974,700.
  • MATTHIAS BODENSTEDT (Chief Financial Officer) purchased 10,870 shares for an estimated $98,808

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$MLTX Hedge Fund Activity

We have seen 100 institutional investors add shares of $MLTX stock to their portfolio, and 70 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$MLTX Analyst Ratings

Wall Street analysts have issued reports on $MLTX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

  • BTIG issued a "Buy" rating on 02/23/2026
  • Needham issued a "Buy" rating on 02/23/2026
  • Goldman Sachs issued a "Sell" rating on 01/15/2026
  • HC Wainwright & Co. issued a "Buy" rating on 01/09/2026
  • Citigroup issued a "Sell" rating on 10/29/2025

To track analyst ratings and price targets for $MLTX, check out Quiver Quantitative's $MLTX forecast page.

$MLTX Price Targets

Multiple analysts have issued price targets for $MLTX recently. We have seen 10 analysts offer price targets for $MLTX in the last 6 months, with a median target of $27.5.

Here are some recent targets:

  • Julian Harrison from BTIG set a target price of $30.0 on 03/30/2026
  • Andy Chen from Wolfe Research set a target price of $24.0 on 03/23/2026
  • Qize Ding from Rothschild & Co set a target price of $40.0 on 03/19/2026
  • Kaveri Pohlman from Clear Street set a target price of $70.0 on 03/11/2026
  • Raghuram Selvaraju from HC Wainwright & Co. set a target price of $40.0 on 03/02/2026
  • Brian Abrahams from RBC Capital set a target price of $13.0 on 03/02/2026
  • Serge Belanger from Needham set a target price of $25.0 on 02/26/2026

You can track data on $MLTX on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article
$APTV stock is down 12% today. Here's what we see in our data.
13 minutes ago | April 1, 2026 2:57 p.m. UTC

$APTV stock has now fallen 12% today, according to our price data from Polygon. There has been approximately $44,187,024 of trading volume.

It has been the 463rd most-searched ticker on Quiver Quantitative over the last day, out of 11,571 total tickers searched.

Here is what we see in our data on $APTV (you can track the company live on Quiver's $APTV stock page):

$APTV Insider Trading Activity

APTV Insider Trades

$APTV insiders have traded $APTV stock on the open market 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $APTV stock by insiders over the last 6 months:

  • VARUN LAROYIA (EVP & Chief Financial Officer) has made 0 purchases and 2 sales selling 19,500 shares for an estimated $1,529,510.
  • KATHERINE H RAMUNDO (EVP, CLO, CCO & Secretary) has made 0 purchases and 2 sales selling 18,000 shares for an estimated $1,517,000.
  • SEAN O MAHONEY sold 7,881 shares for an estimated $603,684
  • HAKAN AGNEVALL purchased 3,700 shares for an estimated $296,917

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$APTV Hedge Fund Activity

We have seen 322 institutional investors add shares of $APTV stock to their portfolio, and 349 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$APTV Government Contracts

We have seen $118,472 of award payments to $APTV over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

$APTV Analyst Ratings

Wall Street analysts have issued reports on $APTV in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Evercore ISI Group issued a "Outperform" rating on 11/24/2025
  • RBC Capital issued a "Outperform" rating on 11/19/2025
  • TD Cowen issued a "Buy" rating on 10/31/2025
  • Wells Fargo issued a "Overweight" rating on 10/31/2025
  • Citigroup issued a "Buy" rating on 10/10/2025

To track analyst ratings and price targets for $APTV, check out Quiver Quantitative's $APTV forecast page.

$APTV Price Targets

Multiple analysts have issued price targets for $APTV recently. We have seen 12 analysts offer price targets for $APTV in the last 6 months, with a median target of $98.5.

Here are some recent targets:

  • Colin Langan from Wells Fargo set a target price of $93.0 on 03/31/2026
  • Tom Narayan from RBC Capital set a target price of $81.0 on 03/31/2026
  • Dan Levy from Barclays set a target price of $77.0 on 03/30/2026
  • Andrew Percoco from Morgan Stanley set a target price of $87.0 on 03/30/2026
  • Joseph Spak from UBS set a target price of $97.0 on 03/12/2026
  • Colin Rusch from Oppenheimer set a target price of $106.0 on 02/03/2026
  • Alexander Potter from Piper Sandler set a target price of $103.0 on 01/08/2026

You can track data on $APTV on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article
$GEVO stock is down 9% today. Here's what we see in our data.
13 minutes ago | April 1, 2026 2:57 p.m. UTC

$GEVO stock has now fallen 9% today, according to our price data from Polygon. There has been approximately $7,536,747 of trading volume.

It has been the 387th most-searched ticker on Quiver Quantitative over the last day, out of 11,571 total tickers searched.

Here is what we see in our data on $GEVO (you can track the company live on Quiver's $GEVO stock page):

$GEVO Insider Trading Activity

GEVO Insider Trades

$GEVO insiders have traded $GEVO stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $GEVO stock by insiders over the last 6 months:

  • CHRISTOPHER MICHAEL RYAN (President & COO) sold 100,000 shares for an estimated $281,870
  • ANGELO AMORELLI sold 100,000 shares for an estimated $250,270
  • GARY W. MIZE sold 107,100 shares for an estimated $250,078
  • OLUWAGBEMILEKE YUSUF AGIRI (CFO) sold 73,284 shares for an estimated $169,183
  • CAROL JANE BATTERSHELL sold 75,597 shares for an estimated $152,781
  • ANDREW SHAFER (Chief Cust Mkt & Brnd Officer) has made 0 purchases and 6 sales selling 55,347 shares for an estimated $123,714.
  • LINDSAY CLINTON FITZGERALD (Chief Public Affairs Officer) sold 20,000 shares for an estimated $50,124
  • DAVAAJARGAL GENDENJAMTS (VP Acctg and Treasurer) sold 2,560 shares for an estimated $5,943

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$GEVO Hedge Fund Activity

We have seen 74 institutional investors add shares of $GEVO stock to their portfolio, and 55 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • UBS GROUP AG removed 3,470,155 shares (-36.4%) from their portfolio in Q4 2025, for an estimated $6,940,310
  • NUVEEN, LLC added 2,146,019 shares (+107.7%) to their portfolio in Q4 2025, for an estimated $4,292,038
  • INVESCO LTD. added 1,719,381 shares (+41.3%) to their portfolio in Q4 2025, for an estimated $3,438,762
  • CITADEL ADVISORS LLC removed 1,280,095 shares (-57.7%) from their portfolio in Q4 2025, for an estimated $2,560,190
  • ROYAL BANK OF CANADA removed 1,095,684 shares (-99.0%) from their portfolio in Q4 2025, for an estimated $2,191,368
  • STATE STREET CORP added 944,287 shares (+12.6%) to their portfolio in Q4 2025, for an estimated $1,888,574
  • RENAISSANCE TECHNOLOGIES LLC added 872,794 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,745,588

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

You can track data on $GEVO on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article
$KRRO stock is up 9% today. Here's what we see in our data.
13 minutes ago | April 1, 2026 2:56 p.m. UTC

$KRRO stock has now risen 9% today, according to our price data from Polygon. There has been approximately $1,065,281 of trading volume.

Here is what we see in our data on $KRRO (you can track the company live on Quiver's $KRRO stock page):

$KRRO Insider Trading Activity

KRRO Insider Trades

$KRRO insiders have traded $KRRO stock on the open market 9 times in the past 6 months. Of those trades, 9 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $KRRO stock by insiders over the last 6 months:

  • SCOTT D SANDELL purchased 207,100 shares for an estimated $2,300,881
  • FOREST BASKETT purchased 207,100 shares for an estimated $2,300,881
  • EDWARD T MATHERS purchased 207,100 shares for an estimated $2,300,881
  • PAUL EDWARD WALKER purchased 207,100 shares for an estimated $2,300,881
  • ANTHONY A. JR. FLORENCE purchased 207,100 shares for an estimated $2,300,881
  • MOHAMAD MAKHZOUMI purchased 207,100 shares for an estimated $2,300,881
  • CARMEN CHANG purchased 207,100 shares for an estimated $2,300,881
  • ENTERPRISE ASSOCIATES 17, L.P. NEW purchased 207,100 shares for an estimated $2,300,881
  • RICK YANG purchased 207,100 shares for an estimated $2,300,881

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$KRRO Hedge Fund Activity

We have seen 46 institutional investors add shares of $KRRO stock to their portfolio, and 51 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$KRRO Analyst Ratings

Wall Street analysts have issued reports on $KRRO in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Clear Street issued a "Buy" rating on 02/19/2026
  • William Blair issued a "Outperform" rating on 02/17/2026
  • HC Wainwright & Co. issued a "Buy" rating on 01/29/2026
  • Piper Sandler issued a "Overweight" rating on 01/29/2026

To track analyst ratings and price targets for $KRRO, check out Quiver Quantitative's $KRRO forecast page.

$KRRO Price Targets

Multiple analysts have issued price targets for $KRRO recently. We have seen 8 analysts offer price targets for $KRRO in the last 6 months, with a median target of $21.0.

Here are some recent targets:

  • Steven Seedhouse from Raymond James set a target price of $23.0 on 03/13/2026
  • Steve Seedhouse from Cantor Fitzgerald set a target price of $22.0 on 03/13/2026
  • Bill Maughan from Clear Street set a target price of $18.0 on 02/19/2026
  • Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $20.0 on 01/29/2026
  • Yasmeen Rahimi from Piper Sandler set a target price of $30.0 on 01/29/2026
  • Keay Nakae from Chardan Capital set a target price of $15.0 on 01/29/2026
  • Kostas Biliouris from Oppenheimer set a target price of $22.0 on 01/28/2026

You can track data on $KRRO on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article
$TH stock is up 32% today. Here's what we see in our data.
13 minutes ago | April 1, 2026 2:56 p.m. UTC

$TH stock has now risen 32% today, according to our price data from Polygon. There has been approximately $55,426,371 of trading volume.

Here is what we see in our data on $TH (you can track the company live on Quiver's $TH stock page):

$TH Insider Trading Activity

TH Insider Trades

$TH insiders have traded $TH stock on the open market 6 times in the past 6 months. Of those trades, 2 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $TH stock by insiders over the last 6 months:

  • STEPHEN ROBERTSON has made 2 purchases buying 270,000 shares for an estimated $1,985,750 and 0 sales.
  • HEIDI DIANE LEWIS (EVP, General Counsel & Sec) has made 0 purchases and 4 sales selling 40,456 shares for an estimated $304,546.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$TH Hedge Fund Activity

We have seen 65 institutional investors add shares of $TH stock to their portfolio, and 59 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$TH Revenue

TH Quarterly Revenue

$TH had revenues of $89.8M in Q4 2025. This is an increase of 7.28% from the same period in the prior year.

You can track TH financials on Quiver Quantitative's TH stock page.

$TH Analyst Ratings

Wall Street analysts have issued reports on $TH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Stifel issued a "Buy" rating on 12/30/2025

To track analyst ratings and price targets for $TH, check out Quiver Quantitative's $TH forecast page.

$TH Price Targets

Multiple analysts have issued price targets for $TH recently. We have seen 2 analysts offer price targets for $TH in the last 6 months, with a median target of $11.0.

Here are some recent targets:

  • Scott Schneeberger from Oppenheimer set a target price of $11.0 on 03/17/2026
  • Stephen Gengaro from Stifel set a target price of $11.0 on 12/30/2025

You can track data on $TH on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article
$LWAY stock is up 10% today. Here's what we see in our data.
13 minutes ago | April 1, 2026 2:56 p.m. UTC

$LWAY stock has now risen 10% today, according to our price data from Polygon. There has been approximately $1,888,825 of trading volume.

Here is what we see in our data on $LWAY (you can track the company live on Quiver's $LWAY stock page):

$LWAY Insider Trading Activity

LWAY Insider Trades

$LWAY insiders have traded $LWAY stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $LWAY stock by insiders over the last 6 months:

  • EDWARD SMOLYANSKY has made 0 purchases and 5 sales selling 133,643 shares for an estimated $3,145,150.
  • LUDMILA SMOLYANSKY has made 0 purchases and 8 sales selling 100,000 shares for an estimated $2,363,201.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$LWAY Hedge Fund Activity

We have seen 45 institutional investors add shares of $LWAY stock to their portfolio, and 55 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$LWAY Analyst Ratings

Wall Street analysts have issued reports on $LWAY in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Benchmark issued a "Buy" rating on 11/13/2025

To track analyst ratings and price targets for $LWAY, check out Quiver Quantitative's $LWAY forecast page.

You can track data on $LWAY on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article
$FSLY stock is up 9% today. Here's what we see in our data.
13 minutes ago | April 1, 2026 2:56 p.m. UTC

$FSLY stock has now risen 9% today, according to our price data from Polygon. There has been approximately $137,043,172 of trading volume.

Here is what we see in our data on $FSLY (you can track the company live on Quiver's $FSLY stock page):

$FSLY Insider Trading Activity

FSLY Insider Trades

$FSLY insiders have traded $FSLY stock on the open market 87 times in the past 6 months. Of those trades, 0 have been purchases and 87 have been sales.

Here’s a breakdown of recent trading of $FSLY stock by insiders over the last 6 months:

  • ARTUR BERGMAN (Chief Technology Officer) has made 0 purchases and 58 sales selling 2,566,173 shares for an estimated $40,402,535.
  • CHARLES LACEY III COMPTON (CEO) has made 0 purchases and 16 sales selling 258,666 shares for an estimated $4,883,622.
  • SCOTT R. LOVETT (President, Go to Market) has made 0 purchases and 10 sales selling 243,337 shares for an estimated $4,424,679.
  • RICHARD DEVON DANIELS sold 14,976 shares for an estimated $312,848
  • RICHARD WONG (CFO) has made 0 purchases and 2 sales selling 9,242 shares for an estimated $191,897.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$FSLY Hedge Fund Activity

We have seen 128 institutional investors add shares of $FSLY stock to their portfolio, and 102 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$FSLY Revenue

FSLY Quarterly Revenue

$FSLY had revenues of $172.6M in Q4 2025. This is an increase of 22.79% from the same period in the prior year.

You can track FSLY financials on Quiver Quantitative's FSLY stock page.

$FSLY Analyst Ratings

Wall Street analysts have issued reports on $FSLY in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Keybanc issued a "Overweight" rating on 12/15/2025

To track analyst ratings and price targets for $FSLY, check out Quiver Quantitative's $FSLY forecast page.

$FSLY Price Targets

Multiple analysts have issued price targets for $FSLY recently. We have seen 5 analysts offer price targets for $FSLY in the last 6 months, with a median target of $14.0.

Here are some recent targets:

  • Rishi Jaluria from RBC Capital set a target price of $20.0 on 03/02/2026
  • Fatima Boolani from Citigroup set a target price of $13.0 on 02/13/2026
  • James Fish from Piper Sandler set a target price of $14.0 on 02/12/2026
  • Rudy Kessinger from DA Davidson set a target price of $9.0 on 02/09/2026
  • Jackson Ader from Keybanc set a target price of $14.0 on 12/15/2025

You can track data on $FSLY on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article
$ZLAB stock is up 9% today. Here's what we see in our data.
13 minutes ago | April 1, 2026 2:56 p.m. UTC

$ZLAB stock has now risen 9% today, according to our price data from Polygon. There has been approximately $7,488,465 of trading volume.

Here is what we see in our data on $ZLAB (you can track the company live on Quiver's $ZLAB stock page):

$ZLAB Insider Trading Activity

ZLAB Insider Trades

$ZLAB insiders have traded $ZLAB stock on the open market 18 times in the past 6 months. Of those trades, 1 have been purchases and 17 have been sales.

Here’s a breakdown of recent trading of $ZLAB stock by insiders over the last 6 months:

  • YING DU (Chairperson & CEO) has made 0 purchases and 6 sales selling 201,067 shares for an estimated $3,861,971.
  • FRAZOR TITUS III EDMONDSON (Chief Legal Officer) has made 0 purchases and 4 sales selling 39,829 shares for an estimated $752,293.
  • RAFAEL AMADO (See Remarks) has made 0 purchases and 3 sales selling 23,744 shares for an estimated $416,921.
  • YAJING CHEN (Chief Financial Officer) has made 0 purchases and 3 sales selling 2,399 shares for an estimated $53,779.
  • JOSHUA L SMILEY (See Remarks) sold 1,966 shares for an estimated $36,622
  • RICHARD GAYNOR purchased 1,731 shares for an estimated $32,733

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$ZLAB Hedge Fund Activity

We have seen 67 institutional investors add shares of $ZLAB stock to their portfolio, and 83 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • CAPITAL WORLD INVESTORS removed 6,077,666 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $107,210,028
  • FMR LLC removed 3,261,305 shares (-69.4%) from their portfolio in Q4 2025, for an estimated $57,529,420
  • JANUS HENDERSON GROUP PLC removed 2,049,537 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $36,153,832
  • CLEARBRIDGE INVESTMENTS, LLC removed 1,711,302 shares (-48.6%) from their portfolio in Q4 2025, for an estimated $30,187,367
  • UBS GROUP AG added 1,475,698 shares (+481.4%) to their portfolio in Q4 2025, for an estimated $26,031,312
  • RTW INVESTMENTS, LP added 1,422,156 shares (+25.7%) to their portfolio in Q4 2025, for an estimated $25,086,831
  • WELLINGTON MANAGEMENT GROUP LLP removed 965,597 shares (-56.2%) from their portfolio in Q4 2025, for an estimated $17,033,131

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$ZLAB Price Targets

Multiple analysts have issued price targets for $ZLAB recently. We have seen 3 analysts offer price targets for $ZLAB in the last 6 months, with a median target of $35.0.

Here are some recent targets:

  • Anupam Rama from JP Morgan set a target price of $32.0 on 03/18/2026
  • Li Watsek from Cantor Fitzgerald set a target price of $37.0 on 02/27/2026
  • Michael Yee from UBS set a target price of $35.0 on 01/07/2026

You can track data on $ZLAB on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article
$RBLX stock is up 2% today. Here's what we see in our data.
13 minutes ago | April 1, 2026 2:56 p.m. UTC

$RBLX stock has now risen 2% today, according to our price data from Polygon. There has been approximately $124,215,472 of trading volume.

It has been the 153rd most-searched ticker on Quiver Quantitative over the last day, out of 11,571 total tickers searched.

Here is what we see in our data on $RBLX (you can track the company live on Quiver's $RBLX stock page):

$RBLX Insider Trading Activity

RBLX Insider Trades

$RBLX insiders have traded $RBLX stock on the open market 111 times in the past 6 months. Of those trades, 0 have been purchases and 111 have been sales.

Here’s a breakdown of recent trading of $RBLX stock by insiders over the last 6 months:

  • DAVID BASZUCKI (President & CEO) has made 0 purchases and 25 sales selling 483,541 shares for an estimated $38,568,061.
  • ANTHONY P LEE has made 0 purchases and 33 sales selling 205,000 shares for an estimated $22,551,859.
  • ARVIND CHAKRAVARTHY (Chief People & Systems Officer) has made 0 purchases and 12 sales selling 138,220 shares for an estimated $9,950,586.
  • MARK REINSTRA (Chief Legal Off. & Corp. Sec.) has made 0 purchases and 12 sales selling 130,689 shares for an estimated $9,238,238.
  • MATTHEW D KAUFMAN (Chief Safety Officer) has made 0 purchases and 14 sales selling 84,128 shares for an estimated $7,222,170.
  • NAVEEN K. CHOPRA (Chief Financial Officer) has made 0 purchases and 8 sales selling 32,138 shares for an estimated $2,633,136.
  • AMY MARIE RAWLINGS (Chief Accounting Officer) has made 0 purchases and 7 sales selling 5,593 shares for an estimated $433,320.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$RBLX Hedge Fund Activity

We have seen 457 institutional investors add shares of $RBLX stock to their portfolio, and 531 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$RBLX Revenue

RBLX Quarterly Revenue

$RBLX had revenues of $1.4B in Q4 2025. This is an increase of 43.19% from the same period in the prior year.

You can track RBLX financials on Quiver Quantitative's RBLX stock page.

$RBLX Congressional Stock Trading

Members of Congress have traded $RBLX stock 5 times in the past 6 months. Of those trades, 3 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $RBLX stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$RBLX Analyst Ratings

Wall Street analysts have issued reports on $RBLX in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Roth Capital issued a "Buy" rating on 02/09/2026
  • Wedbush issued a "Outperform" rating on 01/30/2026
  • BTIG issued a "Buy" rating on 01/28/2026
  • Macquarie issued a "Outperform" rating on 11/04/2025
  • Wells Fargo issued a "Overweight" rating on 10/31/2025
  • Goldman Sachs issued a "Buy" rating on 10/31/2025
  • Needham issued a "Buy" rating on 10/31/2025

To track analyst ratings and price targets for $RBLX, check out Quiver Quantitative's $RBLX forecast page.

$RBLX Price Targets

Multiple analysts have issued price targets for $RBLX recently. We have seen 20 analysts offer price targets for $RBLX in the last 6 months, with a median target of $108.5.

Here are some recent targets:

  • Jason Bazinet from Citigroup set a target price of $90.0 on 03/30/2026
  • Franco Granda from DA Davidson set a target price of $65.0 on 03/04/2026
  • Eric Handler from Roth Capital set a target price of $84.0 on 02/09/2026
  • Ross Sandler from Barclays set a target price of $115.0 on 02/09/2026
  • Eric Sheridan from Goldman Sachs set a target price of $140.0 on 02/09/2026
  • Alicia Reese from Wedbush set a target price of $110.0 on 02/06/2026
  • Cory Carpenter from JP Morgan set a target price of $75.0 on 02/06/2026

You can track data on $RBLX on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article
$UNIT stock is up 11% today. Here's what we see in our data.
13 minutes ago | April 1, 2026 2:56 p.m. UTC

$UNIT stock has now risen 11% today, according to our price data from Polygon. There has been approximately $32,447,457 of trading volume.

It has been the 511th most-searched ticker on Quiver Quantitative over the last day, out of 11,571 total tickers searched.

Here is what we see in our data on $UNIT (you can track the company live on Quiver's $UNIT stock page):

$UNIT Insider Trading Activity

UNIT Insider Trades

$UNIT insiders have traded $UNIT stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $UNIT stock by insiders over the last 6 months:

  • CARMEN PEREZ-CARLTON sold 7,500 shares for an estimated $58,575

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$UNIT Hedge Fund Activity

We have seen 114 institutional investors add shares of $UNIT stock to their portfolio, and 131 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$UNIT Revenue

UNIT Quarterly Revenue

$UNIT had revenues of $917.2M in Q4 2025. This is an increase of 212.7% from the same period in the prior year.

You can track UNIT financials on Quiver Quantitative's UNIT stock page.

$UNIT Price Targets

Multiple analysts have issued price targets for $UNIT recently. We have seen 2 analysts offer price targets for $UNIT in the last 6 months, with a median target of $8.5.

Here are some recent targets:

  • Michael Rollins from Citigroup set a target price of $9.0 on 03/09/2026
  • Caleb Stein from Wells Fargo set a target price of $8.0 on 03/05/2026

You can track data on $UNIT on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article
$AVTX stock is up 13% today. Here's what we see in our data.
13 minutes ago | April 1, 2026 2:56 p.m. UTC

$AVTX stock has now risen 13% today, according to our price data from Polygon. There has been approximately $3,198,172 of trading volume.

Here is what we see in our data on $AVTX (you can track the company live on Quiver's $AVTX stock page):

$AVTX Insider Trading Activity

AVTX Insider Trades

$AVTX insiders have traded $AVTX stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $AVTX stock by insiders over the last 6 months:

  • MITTIE DOYLE (Chief Medical Officer) sold 25,492 shares for an estimated $411,606
  • JONATHAN GOLDMAN has made 0 purchases and 2 sales selling 11,367 shares for an estimated $162,936.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$AVTX Hedge Fund Activity

We have seen 58 institutional investors add shares of $AVTX stock to their portfolio, and 27 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$AVTX Revenue

AVTX Quarterly Revenue

$AVTX had revenues of $59K in Q4 2025. This is a decrease of -69.27% from the same period in the prior year.

You can track AVTX financials on Quiver Quantitative's AVTX stock page.

$AVTX Analyst Ratings

Wall Street analysts have issued reports on $AVTX in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • BTIG issued a "Buy" rating on 03/24/2026
  • Guggenheim issued a "Buy" rating on 02/02/2026
  • HC Wainwright & Co. issued a "Buy" rating on 01/15/2026
  • Mizuho issued a "Outperform" rating on 12/18/2025

To track analyst ratings and price targets for $AVTX, check out Quiver Quantitative's $AVTX forecast page.

$AVTX Price Targets

Multiple analysts have issued price targets for $AVTX recently. We have seen 4 analysts offer price targets for $AVTX in the last 6 months, with a median target of $40.0.

Here are some recent targets:

  • Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $40.0 on 03/25/2026
  • Julian Harrison from BTIG set a target price of $40.0 on 03/24/2026
  • Yatin Suneja from Guggenheim set a target price of $50.0 on 02/02/2026
  • Joseph Catanzaro from Mizuho set a target price of $39.0 on 12/18/2025

You can track data on $AVTX on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article
$ALEC stock is up 13% today. Here's what we see in our data.
13 minutes ago | April 1, 2026 2:56 p.m. UTC

$ALEC stock has now risen 13% today, according to our price data from Polygon. There has been approximately $1,145,009 of trading volume.

Here is what we see in our data on $ALEC (you can track the company live on Quiver's $ALEC stock page):

$ALEC Insider Trading Activity

ALEC Insider Trades

$ALEC insiders have traded $ALEC stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $ALEC stock by insiders over the last 6 months:

  • ARNON ROSENTHAL (Chief Executive Officer) sold 104,347 shares for an estimated $116,826
  • SARA KENKARE-MITRA (President and Head of R&D) sold 41,687 shares for an estimated $46,672
  • NEIL LINDSAY BERKLEY (Chief Bus Ofcr & Interim CFO) sold 37,261 shares for an estimated $41,717
  • GRACE WONG-SARAD (Principal Accounting Officer) has made 0 purchases and 5 sales selling 21,255 shares for an estimated $34,629.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$ALEC Hedge Fund Activity

We have seen 62 institutional investors add shares of $ALEC stock to their portfolio, and 80 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$ALEC Analyst Ratings

Wall Street analysts have issued reports on $ALEC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • HC Wainwright & Co. issued a "Buy" rating on 10/22/2025

To track analyst ratings and price targets for $ALEC, check out Quiver Quantitative's $ALEC forecast page.

$ALEC Price Targets

Multiple analysts have issued price targets for $ALEC recently. We have seen 2 analysts offer price targets for $ALEC in the last 6 months, with a median target of $5.5.

Here are some recent targets:

  • Thomas Shrader from BTIG set a target price of $6.0 on 03/10/2026
  • Andrew Fein from HC Wainwright & Co. set a target price of $5.0 on 10/22/2025

You can track data on $ALEC on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article
$EDSA stock is up 16% today. Here's what we see in our data.
13 minutes ago | April 1, 2026 2:56 p.m. UTC

$EDSA stock has now risen 16% today, according to our price data from Polygon. There has been approximately $1,397,526 of trading volume.

It has been the 567th most-searched ticker on Quiver Quantitative over the last day, out of 11,571 total tickers searched.

Here is what we see in our data on $EDSA (you can track the company live on Quiver's $EDSA stock page):

$EDSA Insider Trading Activity

EDSA Insider Trades

$EDSA insiders have traded $EDSA stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $EDSA stock by insiders over the last 6 months:

  • PARDEEP NIJHAWAN (Chief Executive Officer) has made 5 purchases buying 80,571 shares for an estimated $217,035 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$EDSA Hedge Fund Activity

We have seen 11 institutional investors add shares of $EDSA stock to their portfolio, and 9 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

You can track data on $EDSA on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article
AXT slips 3.4% as investors revisit dilution and China export-permit overhang
19 minutes ago | April 1, 2026 2:50 p.m. UTC

AXT, Inc. (AXTI) is down 3.4% today. Here is some analysis on what might have caused this price movement.

Analysis: There does not appear to be a single, company-issued headline driving today’s dip; the move looks consistent with a pullback after a volatile stretch. Selling pressure could be tied to lingering dilution concerns from AXT’s recent equity offering and ongoing uncertainty around China export permits that have been affecting indium phosphide shipments, alongside investor digestion of the company’s latest quarterly results.

Details:

  • AXT closed an underwritten public offering of 8,163,265 shares (including the underwriters’ full overallotment) at $12.25 per share, a deal structure that can weigh on sentiment due to dilution and increased float.
  • In early January 2026, the company reduced its fourth-quarter 2025 revenue expectations, citing fewer-than-expected export control permits for indium phosphide being issued by China’s Ministry of Commerce.
  • In its February 19, 2026 earnings release for Q4 and full-year 2025, AXT reported Q4 revenue of $23.0 million and discussed the export-permit headwind while positioning indium phosphide demand as tied to AI infrastructure build-outs.
  • This could also be amplified by routine profit-taking after sharp prior moves, particularly in smaller-cap semiconductor names where liquidity can magnify day-to-day swings.

    • Sources:

    AXT Investor Relations, SEC (EDGAR)

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $AXTI Insider Trading Activity

    AXTI Insider Trades

    $AXTI insiders have traded $AXTI stock on the open market 33 times in the past 6 months. Of those trades, 0 have been purchases and 33 have been sales.

    Here’s a breakdown of recent trading of $AXTI stock by insiders over the last 6 months:

    • MORRIS S YOUNG (CEO) has made 0 purchases and 9 sales selling 547,756 shares for an estimated $17,101,998.
    • GARY L FISCHER (CFO) has made 0 purchases and 6 sales selling 293,239 shares for an estimated $6,441,054.
    • JESSE CHEN has made 0 purchases and 10 sales selling 99,812 shares for an estimated $4,325,687.
    • DAVID C CHANG has made 0 purchases and 7 sales selling 235,000 shares for an estimated $4,300,347.
    • LEONARD J LEBLANC sold 3,637 shares for an estimated $30,587

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

    $AXTI Hedge Fund Activity

    We have seen 84 institutional investors add shares of $AXTI stock to their portfolio, and 25 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    $AXTI Analyst Ratings

    Wall Street analysts have issued reports on $AXTI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • B. Riley Securities issued a "Buy" rating on 10/31/2025

    To track analyst ratings and price targets for $AXTI, check out Quiver Quantitative's $AXTI forecast page.

    $AXTI Price Targets

    Multiple analysts have issued price targets for $AXTI recently. We have seen 3 analysts offer price targets for $AXTI in the last 6 months, with a median target of $21.0.

    Here are some recent targets:

    • Matt Bryson from Wedbush set a target price of $28.0 on 02/20/2026
    • Dave Kang from B. Riley Securities set a target price of $21.0 on 02/20/2026
    • Charles Shi from Needham set a target price of $10.0 on 10/31/2025

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Read Full Article
    RH sinks 22% after Q4 earnings miss and softer fiscal 2026 outlook
    19 minutes ago | April 1, 2026 2:50 p.m. UTC

    RH (RH) is down 22.2% today. Here is some analysis on what might have caused this price movement.

    Analysis: RH shares appear to be sliding after the company posted a quarterly earnings miss and issued a comparatively cautious fiscal 2026 outlook, with profitability pressured by planned spending on expansion and pre-opening costs. Investors also seemed to react to management commentary that recent results were affected by tariff-related sourcing changes and late-quarter weather disruption.

    Details:

  • RH reported fiscal Q4 net revenue of $842.6 million and quarterly profit of $28.8 million (period ended Jan. 31, 2026), with results coming in below typical Wall Street expectations for the quarter.
  • Adjusted earnings were about $1.53 per share versus an expectations baseline near $2.2, a shortfall that likely drove immediate repricing in the stock.
  • For fiscal 2026, RH guided to revenue growth of roughly 4% to 8% and adjusted EBITDA margin of about 14% to 16%, implying margin pressure versus the prior year as the company funds expansion initiatives.
  • Management indicated Q4 net revenues were negatively impacted by about $30 million tied to tariff-related resourcing/backorder dynamics and about $10 million tied to adverse weather late in the quarter.

    • Sources:

    RH Investor Relations / SEC filing, Associated Press, Investing.com

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $RH Insider Trading Activity

    RH Insider Trades

    $RH insiders have traded $RH stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.

    Here’s a breakdown of recent trading of $RH stock by insiders over the last 6 months:

    • ERI CHAYA (SEE REMARKS) has made 0 purchases and 7 sales selling 14,000 shares for an estimated $1,853,330.
    • MARK S DEMILIO has made 0 purchases and 4 sales selling 5,154 shares for an estimated $1,100,147.

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

    $RH Hedge Fund Activity

    We have seen 204 institutional investors add shares of $RH stock to their portfolio, and 206 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    $RH Analyst Ratings

    Wall Street analysts have issued reports on $RH in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • TD Cowen issued a "Buy" rating on 01/20/2026
    • Morgan Stanley issued a "Overweight" rating on 01/15/2026

    To track analyst ratings and price targets for $RH, check out Quiver Quantitative's $RH forecast page.

    $RH Price Targets

    Multiple analysts have issued price targets for $RH recently. We have seen 10 analysts offer price targets for $RH in the last 6 months, with a median target of $175.0.

    Here are some recent targets:

    • Simeon Gutman from Morgan Stanley set a target price of $240.0 on 04/01/2026
    • Cristina Fernandez from Telsey Advisory Group set a target price of $140.0 on 04/01/2026
    • Max Rakhlenko from TD Cowen set a target price of $200.0 on 03/30/2026
    • Michael Lasser from UBS set a target price of $160.0 on 03/17/2026
    • Zachary Fadem from Wells Fargo set a target price of $225.0 on 03/13/2026
    • Kate McShane from Goldman Sachs set a target price of $144.0 on 12/15/2025
    • Seth Sigman from Barclays set a target price of $283.0 on 12/15/2025

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Read Full Article
    Cyclerion Therapeutics surges as it agrees to merge with Korsana Biosciences in a deal backed by a large private financing
    19 minutes ago | April 1, 2026 2:50 p.m. UTC

    Cyclerion Therapeutics (CYCN) is up 332.9% today. Here is some analysis on what might have caused this price movement.

    Analysis: CYCN appears to be rallying after the company announced a definitive all-stock merger agreement with privately held Korsana Biosciences, alongside a large concurrent private financing planned to close in connection with the transaction. In micro-cap situations like this, headline corporate actions can also trigger outsized moves due to positioning shifts and limited liquidity.

    Details:

  • Cyclerion and Korsana announced a definitive merger agreement in which the combined company is expected to operate as Korsana Biosciences and trade on Nasdaq under the ticker “KRSA.”
  • The transaction is expected to close in the third quarter of 2026, subject to customary conditions including shareholder approvals and an SEC registration statement for shares to be issued.
  • The companies disclosed an oversubscribed private investment with expected gross proceeds of approximately $380 million, intended to fund the combined company’s operations into 2029.
  • Pre-merger Cyclerion shareholders are expected to own about 1.5% of the combined company at closing, with the final percentage subject to adjustment based on Cyclerion’s net cash.

    • Sources:

    Cyclerion Therapeutics (Investor Relations/press release), Business Wire, Reuters

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $CYCN Hedge Fund Activity

    We have seen 8 institutional investors add shares of $CYCN stock to their portfolio, and 5 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Read Full Article
    Vertiv jumps as investors extend AI data-center infrastructure trade
    19 minutes ago | April 1, 2026 2:50 p.m. UTC

    Vertiv Holdings Co (VRT) is up 5.9% today. Here is some analysis on what might have caused this price movement.

    Analysis: The move appears tied to continued bullish positioning around AI data-center power and cooling demand, reinforced by Vertiv’s recent order/backlog commentary and 2026 outlook. Momentum may also be benefiting from ongoing index-related demand after the company’s recent S&P 500 addition and from improved financial flexibility following a recent refinancing.

    Details:

  • In its most recent quarterly results, the company highlighted sharply higher organic orders and discussed a large backlog, supporting expectations for sustained demand in high-density compute and liquid-cooling deployments.
  • The company also issued 2026 guidance alongside those results, which helped frame a higher growth and margin profile than many investors had expected for data-center infrastructure suppliers.
  • Vertiv recently completed a senior notes offering and put a new revolving credit facility in place, a step that can improve liquidity and funding capacity as it scales to meet data-center demand.
  • This could also be a continuation of index-tracking flows and “AI infrastructure” thematic buying following its recent S&P 500 inclusion, which can temporarily increase demand for shares.

    • Sources:

    Vertiv Investor Relations, Stock Titan, Quiver Quantitative

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $VRT Insider Trading Activity

    VRT Insider Trades

    $VRT insiders have traded $VRT stock on the open market 65 times in the past 6 months. Of those trades, 0 have been purchases and 65 have been sales.

    Here’s a breakdown of recent trading of $VRT stock by insiders over the last 6 months:

    • ROGER FRADIN has made 0 purchases and 20 sales selling 203,333 shares for an estimated $51,397,591.
    • STEVEN REINEMUND has made 0 purchases and 18 sales selling 100,000 shares for an estimated $25,394,523.
    • EDWARD L MONSER has made 0 purchases and 12 sales selling 77,294 shares for an estimated $18,974,827.
    • DAVID M COTE (Executive Chairman) has made 0 purchases and 8 sales selling 40,000 shares for an estimated $10,211,592.
    • JAN VAN DOKKUM has made 0 purchases and 2 sales selling 38,647 shares for an estimated $9,849,836.
    • ANDERS KARLBORG (EVP, Man., Logistics and Op Ex) has made 0 purchases and 4 sales selling 30,487 shares for an estimated $7,527,885.
    • STEPHEN LIANG (Chief Technology Officer & EVP) sold 5,501 shares for an estimated $937,810

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

    $VRT Hedge Fund Activity

    We have seen 812 institutional investors add shares of $VRT stock to their portfolio, and 638 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    $VRT Congressional Stock Trading

    Members of Congress have traded $VRT stock 7 times in the past 6 months. Of those trades, 4 have been purchases and 3 have been sales.

    Here’s a breakdown of recent trading of $VRT stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

    $VRT Analyst Ratings

    Wall Street analysts have issued reports on $VRT in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Morgan Stanley issued a "Overweight" rating on 10/23/2025
    • TD Cowen issued a "Buy" rating on 10/23/2025
    • Goldman Sachs issued a "Buy" rating on 10/23/2025
    • Citigroup issued a "Buy" rating on 10/23/2025
    • UBS issued a "Buy" rating on 10/23/2025
    • Roth Capital issued a "Buy" rating on 10/21/2025
    • Mizuho issued a "Outperform" rating on 10/17/2025

    To track analyst ratings and price targets for $VRT, check out Quiver Quantitative's $VRT forecast page.

    $VRT Price Targets

    Multiple analysts have issued price targets for $VRT recently. We have seen 14 analysts offer price targets for $VRT in the last 6 months, with a median target of $242.5.

    Here are some recent targets:

    • Stephen Volkmann from Jefferies set a target price of $260.0 on 03/31/2026
    • Wesley Brooks from HSBC set a target price of $325.0 on 03/25/2026
    • Brett Linzey from Mizuho set a target price of $290.0 on 02/12/2026
    • Julian Mitchell from Barclays set a target price of $281.0 on 02/12/2026
    • Mark Delaney from Goldman Sachs set a target price of $277.0 on 02/12/2026
    • Deane Dray from RBC Capital set a target price of $266.0 on 02/12/2026
    • Andrew Kaplowitz from Citigroup set a target price of $286.0 on 02/12/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Read Full Article
    Philip Morris slides as new April 1 regulatory and tax changes add near-term uncertainty for smoke-free growth
    19 minutes ago | April 1, 2026 2:50 p.m. UTC

    Philip Morris International Inc. (PM) is down 5.0% today. Here is some analysis on what might have caused this price movement.

    Analysis: The pullback appears tied to investors re-pricing near-term growth and margin expectations as multiple April 1 policy changes take effect, including tobacco tax adjustments in Japan and a new restriction on nicotine pouches in France. Even if long-term smoke-free momentum remains intact, these kinds of step-changes can create short-term shipment volatility, pricing sensitivity, and demand uncertainty.

    Details:

  • Japan’s tobacco tax hikes begin April 1, 2026, with changes that affect heated tobacco economics and have been flagged as a potential headwind that can distort volumes around implementation dates.
  • Philip Morris’ Japan business had planned price increases for certain IQOS consumables starting April 1, 2026, consistent with the tax adjustments, which can temporarily pressure unit demand as consumers adjust.
  • France’s nicotine pouch ban/restriction is scheduled to start April 1, 2026, which could weigh on European oral nicotine category growth expectations and raise questions about spillover regulation elsewhere.
  • This could also reflect some profit-taking after a strong run into 2026, with investors focusing on “transitory” 2026 headwinds highlighted in prior company communications.

    • Sources:

    SEC (EDGAR), Service-Public.fr, The Japan Times

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $PM Hedge Fund Activity

    We have seen 1,218 institutional investors add shares of $PM stock to their portfolio, and 1,156 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    $PM Congressional Stock Trading

    Members of Congress have traded $PM stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

    Here’s a breakdown of recent trading of $PM stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

    $PM Analyst Ratings

    Wall Street analysts have issued reports on $PM in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • JP Morgan issued a "Overweight" rating on 11/26/2025
    • Barclays issued a "Overweight" rating on 11/17/2025

    To track analyst ratings and price targets for $PM, check out Quiver Quantitative's $PM forecast page.

    $PM Price Targets

    Multiple analysts have issued price targets for $PM recently. We have seen 5 analysts offer price targets for $PM in the last 6 months, with a median target of $185.0.

    Here are some recent targets:

    • Gerald Pascarelli from Needham set a target price of $205.0 on 02/10/2026
    • Simon Hales from Citigroup set a target price of $210.0 on 02/10/2026
    • Edward Mundy from Jefferies set a target price of $180.0 on 01/20/2026
    • Jared Dinges from JP Morgan set a target price of $185.0 on 11/26/2025
    • Gaurav Jain from Barclays set a target price of $180.0 on 11/17/2025

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Read Full Article
    Occidental Petroleum shares fall as crude oil retreats and traders lock in gains
    19 minutes ago | April 1, 2026 2:50 p.m. UTC

    Occidental Petroleum (OXY) is down 4.2% today. Here is some analysis on what might have caused this price movement.

    Analysis: The decline appears tied to a pullback in crude oil prices after recent geopolitical-driven strength, which can pressure oil-levered equities even when company fundamentals are unchanged. The move also looks consistent with short-term profit-taking after a strong run in the stock and the broader energy complex.

    Details:

  • Crude prices moved lower as markets priced in improving odds of de-escalation in the Iran conflict, reducing the “war-risk premium” that had supported oil in March.
  • U.S. inventory chatter also weighed on sentiment, with industry data pointing to a much larger-than-expected weekly crude stock build, which can signal softer near-term balances.
  • Occidental’s most recent quarterly update highlighted ongoing balance-sheet repair after the OxyChem transaction and reiterated a higher quarterly dividend of $0.26 per share, but those items were already widely digested by investors.
  • This could also be a technical pullback: when oil slips quickly, leveraged energy names often overreact on the downside as traders reduce exposure.

    • Sources:

    ING Think, Occidental Petroleum (news release), Occidental Petroleum (earnings release)

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $OXY Insider Trading Activity

    OXY Insider Trades

    $OXY insiders have traded $OXY stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

    Here’s a breakdown of recent trading of $OXY stock by insiders over the last 6 months:

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

    $OXY Hedge Fund Activity

    We have seen 418 institutional investors add shares of $OXY stock to their portfolio, and 618 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    $OXY Congressional Stock Trading

    Members of Congress have traded $OXY stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.

    Here’s a breakdown of recent trading of $OXY stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

    $OXY Analyst Ratings

    Wall Street analysts have issued reports on $OXY in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Susquehanna issued a "Positive" rating on 11/13/2025
    • Wells Fargo issued a "Underweight" rating on 11/12/2025

    To track analyst ratings and price targets for $OXY, check out Quiver Quantitative's $OXY forecast page.

    $OXY Price Targets

    Multiple analysts have issued price targets for $OXY recently. We have seen 15 analysts offer price targets for $OXY in the last 6 months, with a median target of $60.0.

    Here are some recent targets:

    • Scott Gruber from Citigroup set a target price of $67.0 on 03/30/2026
    • Gabe Daoud from Truist Securities set a target price of $65.0 on 03/24/2026
    • Samantha Hoh from HSBC set a target price of $68.0 on 03/20/2026
    • Arun Jayaram from JP Morgan set a target price of $63.0 on 03/20/2026
    • Nitin Kumar from Mizuho set a target price of $72.0 on 03/17/2026
    • Betty Jiang from Barclays set a target price of $59.0 on 03/16/2026
    • Mark Lear from Piper Sandler set a target price of $66.0 on 03/12/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Read Full Article
    Applied Optoelectronics jumps as investors reprice hyperscaler 800G/1.6T order momentum
    19 minutes ago | April 1, 2026 2:50 p.m. UTC

    Applied Optoelectronics (AAOI) is up 12.5% today. Here is some analysis on what might have caused this price movement.

    Analysis: AAOI’s move appears tied to continued investor enthusiasm around recent hyperscale data-center transceiver orders, which point to strengthening demand for high-speed optics used in AI networking. The rally also looks like a momentum follow-through as traders focus on the company’s expanding 800G and emerging 1.6T production ramp.

    Details:

  • In a March 23, 2026 press release, the company announced a new volume order totaling more than $53 million for 800G single-mode data center transceivers from one of its major hyperscale customers.
  • The company indicated shipments for the 800G order are expected to begin in the second quarter of 2026 and run into mid-third quarter 2026, aligning with AI-driven network-capacity expansion cycles.
  • Management framed the 800G order as arriving shortly after its March 9, 2026 announcement of a first volume order for 1.6T data center transceivers totaling more than $200 million from the same long-term major customer.
  • The March 9 update also highlighted manufacturing scale-up efforts (including ongoing expansion in Taiwan and construction at its Sugar Land, Texas facility), which can support the market’s “AI optics ramp” narrative.

    • Sources:

    GlobeNewswire, Semiconductor Today, Investing.com

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $AAOI Insider Trading Activity

    AAOI Insider Trades

    $AAOI insiders have traded $AAOI stock on the open market 24 times in the past 6 months. Of those trades, 0 have been purchases and 24 have been sales.

    Here’s a breakdown of recent trading of $AAOI stock by insiders over the last 6 months:

    • ELIZABETH G LOBOA has made 0 purchases and 2 sales selling 106,468 shares for an estimated $9,925,189.
    • DAVID C KUO (*** See Remarks) has made 0 purchases and 5 sales selling 73,500 shares for an estimated $4,949,140.
    • SHU-HUA (JOSHUA) YEH (*** See Remarks) sold 50,000 shares for an estimated $4,854,880
    • HUNG-LUN (FRED) CHANG (*** See Remarks) sold 36,400 shares for an estimated $3,648,918
    • CYNTHIA DELANEY sold 21,000 shares for an estimated $2,058,344
    • STEFAN J. MURRY (Chief Financial Officer) has made 0 purchases and 10 sales selling 36,000 shares for an estimated $1,912,111.
    • WILLIAM H YEH sold 15,000 shares for an estimated $1,586,338
    • MIN-CHU (MIKE) CHEN has made 0 purchases and 2 sales selling 11,335 shares for an estimated $1,203,016.
    • RICHARD B BLACK sold 3,231 shares for an estimated $306,945

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

    $AAOI Hedge Fund Activity

    We have seen 150 institutional investors add shares of $AAOI stock to their portfolio, and 73 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • INVESCO LTD. added 3,446,150 shares (+5208.9%) to their portfolio in Q4 2025, for an estimated $120,132,789
    • PRICE T ROWE ASSOCIATES INC /MD/ added 2,188,630 shares (+5321.6%) to their portfolio in Q4 2025, for an estimated $76,295,641
    • JANE STREET GROUP, LLC added 1,644,757 shares (+4312.8%) to their portfolio in Q4 2025, for an estimated $57,336,229
    • D. E. SHAW & CO., INC. added 1,366,856 shares (+inf%) to their portfolio in Q4 2025, for an estimated $47,648,600
    • CITIGROUP INC removed 1,145,566 shares (-98.7%) from their portfolio in Q4 2025, for an estimated $39,934,430
    • CLOUDALPHA CAPITAL MANAGEMENT LIMITED/HONG KONG removed 1,078,750 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $37,605,225
    • MORGAN STANLEY added 1,038,775 shares (+157.1%) to their portfolio in Q4 2025, for an estimated $36,211,696

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    $AAOI Analyst Ratings

    Wall Street analysts have issued reports on $AAOI in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Rosenblatt issued a "Buy" rating on 12/19/2025
    • Needham issued a "Buy" rating on 12/11/2025
    • Northland Capital Markets issued a "Outperform" rating on 11/17/2025
    • B. Riley Securities issued a "Sell" rating on 11/10/2025

    To track analyst ratings and price targets for $AAOI, check out Quiver Quantitative's $AAOI forecast page.

    $AAOI Price Targets

    Multiple analysts have issued price targets for $AAOI recently. We have seen 4 analysts offer price targets for $AAOI in the last 6 months, with a median target of $67.0.

    Here are some recent targets:

    • Mike Genovese from Rosenblatt set a target price of $140.0 on 03/09/2026
    • Ryan Koontz from Needham set a target price of $80.0 on 02/27/2026
    • David Kang from B. Riley Securities set a target price of $54.0 on 02/27/2026
    • Tim Savageaux from Northland Capital Markets set a target price of $35.0 on 11/17/2025

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Read Full Article
    Seagate shares jump as bullish new coverage and AI-storage outlook fuel optimism
    19 minutes ago | April 1, 2026 2:50 p.m. UTC

    Seagate Technology Holdings plc (STX) is up 7.3% today. Here is some analysis on what might have caused this price movement.

    Analysis: The move appears tied to fresh bullish sell-side commentary that reinforced the “AI storage” demand narrative and valuation upside, coming on top of Seagate’s already-strong recent earnings and forward guidance. With investors focused on nearline HDD pricing and capacity tightness into 2026, incremental positive coverage can have an outsized impact on momentum.

    Details:

  • JPMorgan initiated coverage with an Overweight rating and a $525 price target, framing Seagate as a beneficiary of structurally stronger nearline HDD demand and improving margins.
  • In its fiscal Q2 2026 results (quarter ended January 2, 2026), Seagate posted results that management positioned as being supported by a favorable mass-capacity storage demand backdrop and provided Q3 guidance.
  • Company commentary in recent earnings materials emphasized AI-driven data growth as a key driver alongside traditional cloud workloads, helping investors underwrite higher-capacity product demand and firmer pricing.
  • Separately, Seagate closed privately negotiated exchanges of $600 million principal amount of exchangeable notes for cash and shares, an action that can be viewed as balance-sheet management while the stock is strong.

    • Sources:

    Seagate Investor Relations, SEC, Investing.com

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $STX Insider Trading Activity

    STX Insider Trades

    $STX insiders have traded $STX stock on the open market 141 times in the past 6 months. Of those trades, 0 have been purchases and 141 have been sales.

    Here’s a breakdown of recent trading of $STX stock by insiders over the last 6 months:

    • WILLIAM D MOSLEY (CEO) has made 0 purchases and 90 sales selling 144,584 shares for an estimated $47,666,920.
    • GIANLUCA ROMANO (EVP & CFO) has made 0 purchases and 30 sales selling 62,023 shares for an estimated $17,538,753.
    • BAN SENG TEH (EVP & Chief Commercial Officer) has made 0 purchases and 8 sales selling 32,439 shares for an estimated $12,295,458.
    • KIAN FATT CHONG (EVP Global Operations) has made 0 purchases and 2 sales selling 12,924 shares for an estimated $4,360,949.
    • SHANKAR ARUMUGAVELU sold 5,000 shares for an estimated $1,472,825
    • JAY L GELDMACHER has made 0 purchases and 2 sales selling 2,175 shares for an estimated $750,798.
    • STEPHANIE TILENIUS sold 2,046 shares for an estimated $545,084
    • YOLANDA LEE CONYERS has made 0 purchases and 2 sales selling 1,500 shares for an estimated $499,875.
    • JAMES CI LEE (EVP & CLO) has made 0 purchases and 2 sales selling 1,370 shares for an estimated $436,195.
    • JOHN CHRISTOPHER MORRIS (EVP & CTO) has made 0 purchases and 3 sales selling 465 shares for an estimated $173,656.

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

    $STX Hedge Fund Activity

    We have seen 625 institutional investors add shares of $STX stock to their portfolio, and 492 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    $STX Congressional Stock Trading

    Members of Congress have traded $STX stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

    Here’s a breakdown of recent trading of $STX stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

    $STX Analyst Ratings

    Wall Street analysts have issued reports on $STX in the last several months. We have seen 9 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Rosenblatt issued a "Buy" rating on 01/28/2026
    • Morgan Stanley issued a "Overweight" rating on 01/22/2026
    • B of A Securities issued a "Buy" rating on 01/20/2026
    • Citigroup issued a "Buy" rating on 01/20/2026
    • China Renaissance issued a "Buy" rating on 12/05/2025
    • Loop Capital issued a "Buy" rating on 11/10/2025
    • Susquehanna issued a "Negative" rating on 10/29/2025

    To track analyst ratings and price targets for $STX, check out Quiver Quantitative's $STX forecast page.

    $STX Price Targets

    Multiple analysts have issued price targets for $STX recently. We have seen 19 analysts offer price targets for $STX in the last 6 months, with a median target of $425.0.

    Here are some recent targets:

    • Mark Newman from Bernstein set a target price of $620.0 on 03/31/2026
    • Samik Chatterjee from JP Morgan set a target price of $525.0 on 03/30/2026
    • Vijay Rakesh from Mizuho set a target price of $475.0 on 02/17/2026
    • Asiya Merchant from Citigroup set a target price of $480.0 on 02/06/2026
    • C.J. Muse from Cantor Fitzgerald set a target price of $650.0 on 02/04/2026
    • Tristan Gerra from Baird set a target price of $505.0 on 01/29/2026
    • Tom O'Malley from Barclays set a target price of $425.0 on 01/28/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Read Full Article
    Newmont gains as gold rebounds and miners catch a bid
    19 minutes ago | April 1, 2026 2:50 p.m. UTC

    Newmont Corporation (NEM) is up 4.7% today. Here is some analysis on what might have caused this price movement.

    Analysis: The move appears primarily tied to strength in gold prices, which tends to lift large-cap gold miners with high operating leverage to bullion. Newmont may also be benefiting from renewed interest in the sector after outlining its 2026 outlook and capital allocation priorities in its latest results update.

    Details:

  • Gold prices were higher in early Wednesday trading, helping support sentiment toward precious-metals equities.
  • Gold miners broadly moved higher alongside bullion in recent sessions when spot gold rose and macro concerns (rates, inflation expectations, geopolitics) pushed investors back toward defensive exposures.
  • Newmont recently reported full-year results and provided 2026 guidance, alongside an updated capital allocation framework, which can reinforce the stock’s sensitivity to improving gold tape.
  • This could also reflect a rotation into miners after a tough March for bullion, as some investors position for a potential early-April rebound in gold.

    • Sources:

    Newmont (Investor Relations), Associated Press, Business Recorder, Sahm Capital

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $NEM Insider Trading Activity

    NEM Insider Trades

    $NEM insiders have traded $NEM stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.

    Here’s a breakdown of recent trading of $NEM stock by insiders over the last 6 months:

    • DAVID JAMES FRY (Group Head Projects & Studies) sold 18,394 shares for an estimated $2,050,037
    • DAVID JOHN THORNTON (MD, Americas) sold 8,060 shares for an estimated $973,486
    • MARK C RODGERS (MD, Africa-Asia Pacific) has made 0 purchases and 2 sales selling 5,804 shares for an estimated $741,971.
    • BRUCE R BROOK has made 0 purchases and 3 sales selling 6,240 shares for an estimated $537,284.
    • THOMAS RONALD PALMER (CEO) sold 5,000 shares for an estimated $406,700
    • PETER TOTH (EVP, Chief Sustain & Dev Off) sold 3,000 shares for an estimated $324,000

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

    $NEM Hedge Fund Activity

    We have seen 834 institutional investors add shares of $NEM stock to their portfolio, and 665 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    $NEM Analyst Ratings

    Wall Street analysts have issued reports on $NEM in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • UBS issued a "Buy" rating on 12/01/2025
    • CIBC issued a "Outperformer" rating on 10/10/2025

    To track analyst ratings and price targets for $NEM, check out Quiver Quantitative's $NEM forecast page.

    $NEM Price Targets

    Multiple analysts have issued price targets for $NEM recently. We have seen 6 analysts offer price targets for $NEM in the last 6 months, with a median target of $145.0.

    Here are some recent targets:

    • Daniel Major from UBS set a target price of $140.0 on 03/27/2026
    • Tanya Jakusconek from Scotiabank set a target price of $151.0 on 03/20/2026
    • Alexander Hacking from Citigroup set a target price of $150.0 on 03/03/2026
    • Bob Brackett from Bernstein set a target price of $157.0 on 02/27/2026
    • Michael Jalonen from B of A Securities set a target price of $115.0 on 10/16/2025
    • Anita Soni from CIBC set a target price of $112.0 on 10/10/2025

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Read Full Article
    ASML shares climb as chip sector rebounds and AI-driven demand narrative strengthens
    19 minutes ago | April 1, 2026 2:50 p.m. UTC

    ASML Holding N.V. (ASML) is up 3.9% today. Here is some analysis on what might have caused this price movement.

    Analysis: ASML appears to be moving higher alongside a broad semiconductor rally, with investors leaning back into AI and advanced-node capex expectations. Sentiment has also been supported by recent visibility into memory-led EUV spending and ASML’s own outlook pointing to 2026 growth driven by higher EUV system sales.

    Details:

  • Semiconductor stocks have been rebounding sharply in recent sessions, lifting many equipment names with the group as risk appetite improved.
  • A major memory manufacturer disclosed a multi-year plan to purchase a large amount of EUV lithography equipment, reinforcing demand for leading-edge tools used in AI-related memory and advanced DRAM production.
  • ASML recently reiterated expectations that 2026 will be a growth year, with commentary highlighting a significant increase in EUV sales and continued growth in its installed base business.
  • This could also reflect positioning ahead of ASML’s next earnings report, with traders anticipating updates on EUV shipment timing, backlog conversion, and High-NA progress.

    • Sources:

    ASML, Yahoo Finance, Tom's Hardware

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $ASML Hedge Fund Activity

    We have seen 924 institutional investors add shares of $ASML stock to their portfolio, and 745 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    $ASML Congressional Stock Trading

    Members of Congress have traded $ASML stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.

    Here’s a breakdown of recent trading of $ASML stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

    $ASML Analyst Ratings

    Wall Street analysts have issued reports on $ASML in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Barclays issued a "Overweight" rating on 01/29/2026
    • RBC Capital issued a "Outperform" rating on 01/15/2026
    • Bernstein issued a "Outperform" rating on 01/05/2026
    • B of A Securities issued a "Buy" rating on 12/03/2025
    • JP Morgan issued a "Overweight" rating on 12/01/2025
    • Wells Fargo issued a "Overweight" rating on 10/16/2025
    • Susquehanna issued a "Positive" rating on 10/10/2025

    To track analyst ratings and price targets for $ASML, check out Quiver Quantitative's $ASML forecast page.

    $ASML Price Targets

    Multiple analysts have issued price targets for $ASML recently. We have seen 7 analysts offer price targets for $ASML in the last 6 months, with a median target of $1518.0.

    Here are some recent targets:

    • David Dai from Bernstein set a target price of $1971.0 on 03/26/2026
    • Srini Pajjuri from RBC Capital set a target price of $1625.0 on 01/29/2026
    • Joseph Quatrochi from Wells Fargo set a target price of $1650.0 on 01/29/2026
    • Leon Chen from KGI Securities set a target price of $1415.0 on 01/15/2026
    • Sandeep Deshpande from JP Morgan set a target price of $1518.0 on 01/14/2026
    • Didier Scemama from B of A Securities set a target price of $1331.0 on 12/03/2025
    • Mehdi Hosseini from Susquehanna set a target price of $1150.0 on 10/10/2025

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Read Full Article
    Exxon Mobil slides as crude prices retreat on renewed Iran ceasefire optimism
    19 minutes ago | April 1, 2026 2:50 p.m. UTC

    Exxon Mobil (XOM) is down 4.7% today. Here is some analysis on what might have caused this price movement.

    Analysis: Exxon shares appear to be tracking a pullback in crude oil after markets reacted to fresh signs that the Iran conflict could de-escalate. When the perceived risk of prolonged supply disruption eases, the “war premium” in oil prices can unwind quickly, pressuring large integrated oil stocks.

    Details:

  • Oil prices moved lower after comments that raised optimism about a potential ceasefire, reducing near-term fears around shipping disruptions and regional supply risks.
  • Brent crude fell back to around the $100-per-barrel level (down roughly 4%–5% on the day in early reports), a sizable single-session move that can translate into broad selling across the energy complex.
  • Broader global equities were stronger on the same risk-on backdrop, which can amplify sector rotation out of energy and into more economically sensitive areas when oil stress appears to be easing.
  • This decline may also reflect profit-taking after a volatile stretch in energy markets, as traders recalibrate expectations for realized prices and downstream margins if crude stabilizes lower.

    • Sources:

    Associated Press, Axios

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $XOM Insider Trading Activity

    XOM Insider Trades

    $XOM insiders have traded $XOM stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

    Here’s a breakdown of recent trading of $XOM stock by insiders over the last 6 months:

    • DARRIN L TALLEY (VP - Corp Strategic Planning) has made 0 purchases and 7 sales selling 17,460 shares for an estimated $2,395,656.

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

    $XOM Hedge Fund Activity

    We have seen 2,076 institutional investors add shares of $XOM stock to their portfolio, and 1,724 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 38,130,356 shares (-70.4%) from their portfolio in Q4 2025, for an estimated $4,588,607,041
    • NORGES BANK added 6,185,309 shares (+10.8%) to their portfolio in Q4 2025, for an estimated $744,340,085
    • JPMORGAN CHASE & CO removed 4,661,338 shares (-6.2%) from their portfolio in Q4 2025, for an estimated $560,945,414
    • FMR LLC added 4,365,511 shares (+3.4%) to their portfolio in Q4 2025, for an estimated $525,345,593
    • PACER ADVISORS, INC. removed 4,344,733 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $522,845,169
    • BARCLAYS PLC removed 4,037,620 shares (-37.7%) from their portfolio in Q4 2025, for an estimated $485,887,190
    • LAZARD ASSET MANAGEMENT LLC removed 3,677,926 shares (-63.3%) from their portfolio in Q4 2025, for an estimated $442,601,614

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    $XOM Congressional Stock Trading

    Members of Congress have traded $XOM stock 8 times in the past 6 months. Of those trades, 5 have been purchases and 3 have been sales.

    Here’s a breakdown of recent trading of $XOM stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

    $XOM Analyst Ratings

    Wall Street analysts have issued reports on $XOM in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Wells Fargo issued a "Overweight" rating on 02/02/2026
    • Barclays issued a "Overweight" rating on 01/21/2026
    • Freedom Capital Markets issued a "Sell" rating on 01/06/2026
    • Jefferies issued a "Buy" rating on 12/10/2025
    • UBS issued a "Buy" rating on 12/01/2025
    • Piper Sandler issued a "Overweight" rating on 11/10/2025
    • Scotiabank issued a "Sector Outperform" rating on 11/03/2025

    To track analyst ratings and price targets for $XOM, check out Quiver Quantitative's $XOM forecast page.

    $XOM Price Targets

    Multiple analysts have issued price targets for $XOM recently. We have seen 16 analysts offer price targets for $XOM in the last 6 months, with a median target of $150.5.

    Here are some recent targets:

    • Devin McDermott from Morgan Stanley set a target price of $172.0 on 03/27/2026
    • Kim Fustier from HSBC set a target price of $158.0 on 03/20/2026
    • Nitin Kumar from Mizuho set a target price of $162.0 on 03/17/2026
    • Betty Jiang from Barclays set a target price of $163.0 on 03/16/2026
    • Ryan Todd from Piper Sandler set a target price of $186.0 on 03/12/2026
    • Jean Ann Salisbury from B of A Securities set a target price of $151.0 on 03/02/2026
    • Alastair Syme from Citigroup set a target price of $150.0 on 03/02/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Read Full Article
    Nike shares slide as weak outlook and China softness overshadow fiscal Q3 beat
    19 minutes ago | April 1, 2026 2:50 p.m. UTC

    Nike, Inc. (NKE) is down 14.2% today. Here is some analysis on what might have caused this price movement.

    Analysis: Nike’s fiscal Q3 results came in better than feared on some top-line and EPS metrics, but the stock sold off as management’s forward commentary pointed to continued revenue pressure and a slower margin recovery. Investors appeared to focus on ongoing weakness in Greater China and an outlook implying the turnaround will take longer to show up in profitability.

    Details:

  • Nike reported fiscal 2026 third-quarter results on March 31, 2026, with revenue around $11.3 billion and earnings of about $0.35 per share.
  • Quarterly profit declined materially year over year, signaling that promotions, product resets, and cost pressures are still weighing on margins.
  • Greater China revenue fell year over year in the quarter, extending a stretch of softness in a key region.
  • Nike guided to a revenue decline for the next quarter (low single digits), and management indicated the financial benefits of current actions are expected to be more visible later rather than immediately.

    • Sources:

    NIKE, Inc. Investor Relations, Associated Press, Investing.com

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $NKE Insider Trading Activity

    NKE Insider Trades

    $NKE insiders have traded $NKE stock on the open market 8 times in the past 6 months. Of those trades, 4 have been purchases and 4 have been sales.

    Here’s a breakdown of recent trading of $NKE stock by insiders over the last 6 months:

    • MARK G PARKER (EXECUTIVE CHAIRMAN) sold 86,078 shares for an estimated $5,577,854
    • TIMOTHY D COOK purchased 50,000 shares for an estimated $2,948,500
    • JORGEN VIG KNUDSTORP purchased 16,150 shares for an estimated $1,002,753
    • ELLIOTT HILL (PRESIDENT & CEO) purchased 16,388 shares for an estimated $1,001,306
    • ROBERT LEINWAND (EVP: Chief Legal Officer) has made 0 purchases and 2 sales selling 9,762 shares for an estimated $617,388.
    • ROBERT HOLMES SWAN purchased 8,691 shares for an estimated $500,080
    • TREASURE HEINLE (EVP: CHIEF PEOPLE OFFICER) sold 4,300 shares for an estimated $306,461

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

    $NKE Hedge Fund Activity

    We have seen 833 institutional investors add shares of $NKE stock to their portfolio, and 1,088 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    $NKE Analyst Ratings

    Wall Street analysts have issued reports on $NKE in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • RBC Capital issued a "Outperform" rating on 01/06/2026
    • Piper Sandler issued a "Overweight" rating on 12/19/2025
    • Truist Securities issued a "Buy" rating on 12/19/2025
    • Goldman Sachs issued a "Buy" rating on 12/19/2025
    • Guggenheim issued a "Buy" rating on 12/10/2025
    • Wells Fargo issued a "Overweight" rating on 11/13/2025
    • BTIG issued a "Buy" rating on 10/15/2025

    To track analyst ratings and price targets for $NKE, check out Quiver Quantitative's $NKE forecast page.

    $NKE Price Targets

    Multiple analysts have issued price targets for $NKE recently. We have seen 17 analysts offer price targets for $NKE in the last 6 months, with a median target of $70.0.

    Here are some recent targets:

    • Simeon Siegel from Guggenheim set a target price of $74.0 on 04/01/2026
    • Cristina Fernandez from Telsey Advisory Group set a target price of $55.0 on 04/01/2026
    • Robert Drbul from BTIG set a target price of $75.0 on 04/01/2026
    • Lorraine Hutchinson from B of A Securities set a target price of $55.0 on 04/01/2026
    • Krisztina Katai from Deutsche Bank set a target price of $54.0 on 03/23/2026
    • Jay Sole from UBS set a target price of $58.0 on 03/19/2026
    • Adrienne Yih from Barclays set a target price of $73.0 on 03/11/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Read Full Article
    Mixed Martial Arts Group Limited Launches Frictionless Onboarding for BJJLink Platform to Accelerate Global Expansion
    29 minutes ago | April 1, 2026 2:40 p.m. UTC

    MMA.INC launches instant onboarding for BJJLink, enhancing customer acquisition and driving scalable growth in the combat sports market.

    Quiver AI Summary

    Mixed Martial Arts Group Limited (MMA) has announced the launch of a frictionless online self-onboarding feature for its BJJLink platform, allowing martial arts academies worldwide to quickly and easily activate and use the service, significantly enhancing customer acquisition. This development follows impressive growth, including a 145% year-on-year increase in subscription revenue and substantial gains in transaction volume. The company plans to implement AI-driven sales agents to further streamline conversion processes. This initiative positions BJJLink as an efficient and scalable platform in the combat sports sector, aiming to capitalize on a fragmented global market and drive increased subscription and transaction revenues.

    Potential Positives

    • Instant onboarding eliminates sales friction, enabling rapid global customer acquisition.
    • 145% year-on-year subscription revenue expansion indicates strong business growth and momentum.
    • AI-driven sales agents will further automate and accelerate customer acquisition, reducing costs.
    • BJJLink positions the company as a scalable global platform within a fragmented market, enhancing its competitive advantage.

    Potential Negatives

    • The press release heavily relies on forward-looking statements, which may not materialize as anticipated, thereby introducing significant uncertainty regarding the future performance of the company.
    • There is a notable emphasis on rapid growth in subscription revenue, but the reliance on factors like participant churn and cancellations could undermine these optimistic projections, indicating potential instability.
    • The press release contains a disclaimer urging investors to consult their advisors before making investment decisions, which may suggest a lack of confidence in the company's standing or readiness to assertively promote its offerings.

    FAQ

    What is the BJJLink platform's new feature?

    The BJJLink platform has launched frictionless online self-onboarding for martial arts academies, enabling instant activation without sales intervention.

    How has MMA.INC's subscription revenue changed recently?

    MMA.INC experienced a 145% year-on-year growth in subscription revenue, reflecting strong demand and market expansion.

    What role does AI play in BJJLink's growth strategy?

    AI-driven sales agents are being introduced to automate lead engagement and conversion, accelerating growth and reducing acquisition costs.

    In how many countries does MMA.INC operate?

    MMA.INC operates across 22 countries, connecting local gyms with global communities and customers in a unified ecosystem.

    What benefits do users get from MMA.INC's platform?

    Users can earn Experience Points (XP) through training and activities, which can be redeemed for real rewards on the platform.

    Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.


    $MMA Hedge Fund Activity

    We have seen 4 institutional investors add shares of $MMA stock to their portfolio, and 2 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • TWO SIGMA SECURITIES, LLC removed 11,024 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $12,346
    • CENTIVA CAPITAL, LP added 10,380 shares (+inf%) to their portfolio in Q4 2025, for an estimated $11,625
    • OSAIC HOLDINGS, INC. removed 5,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $5,600
    • UBS GROUP AG added 2,218 shares (+122.2%) to their portfolio in Q4 2025, for an estimated $2,484
    • TUCKER ASSET MANAGEMENT LLC added 750 shares (+inf%) to their portfolio in Q4 2025, for an estimated $840
    • MORGAN STANLEY added 700 shares (+inf%) to their portfolio in Q4 2025, for an estimated $784
    • WELLS FARGO & COMPANY/MN added 0 shares (+0.0%) to their portfolio in Q4 2025, for an estimated $0

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    Full Release

    Highlights

    • Instant onboarding eliminates sales friction, enabling rapid global customer acquisition
    • Unlocks scalable growth engine following 145% YoY subscription revenue expansion
    • Activates funnel across 18,000+ gyms and a large fragmented global market
    • AI-driven sales agents to automate conversion and accelerate signups
    • Designed to drive higher transaction volumes and recurring revenue at scale

    New York, NY, April 01, 2026 (GLOBE NEWSWIRE) -- Mixed Martial Arts Group Limited (NYSE American: MMA) (“MMA” or the “Company” and doing business as MMA.INC), a technology driven ecosystem at the forefront of the global combat sports industry today announced the launch of frictionless online self-onboarding for its BJJLink platform, enabling martial arts academies worldwide to instantly activate and start using the platform without requiring any direct sales intervention.

    This release materially increases BJJLink’s ability to scale customer acquisition, converting global demand into active paying academies at significantly higher speed and lower cost.

    The launch builds on strong recent momentum, including 145% year-on-year subscription revenue growth and 141% growth in transaction volume to an annualized run-rate of approximately $16.2 million as of February 2026 , positioning BJJLink as a rapidly scaling subscription and payments platform within the global combat sports market.

    “Removing onboarding friction is a major unlock for our growth,” said Nick Langton, Founder and CEO of MMA.INC. “We can now convert demand into active academies instantly, anywhere in the world. This materially expands our ability to scale.”

    The Company also expects to layer in AI-powered sales and onboarding agents , enabling automated lead engagement, qualification, and conversion, thus further accelerating growth while reducing customer acquisition costs.

    As adoption scales, BJJLink captures recurring subscription revenue alongside growing transaction flows across memberships and in-gym commerce which creates a compounding growth model driven by increased participation, higher transaction volume, and expanding lifetime value per customer .

    The Company believes this milestone positions BJJLink as a scalable global platform capable of rapidly onboarding and monetizing a fragmented market, reinforcing MMA.INC’s strategy to build a category-defining technology and payments ecosystem for combat sports.

    About Mixed Martial Arts Group Limited

    With over 5 million social media followers, 530,000 user profiles, 75,000+ active students, 18,000 published gyms and 800 verified gyms across 22 countries across its various assets, MMA.INC continues to transform the martial arts landscape and deliver unparalleled value to its stakeholders:

    • A Global Platform: Operating across 22 countries, MMA.INC connects local gyms with global communities and customers in a single, connected network of value.
    • Get Paid to Train : Engaging in training, streaming, coaching or simply supporting any activity, will earn Experience Points (XP), which is transparently logged on chain and can be redeemed for real rewards.
    • One Unified Ecosystem: With existing platform assets including BJJLink, TrainAlta, Hype and MixedMartialArts.com, MMA.INC provides a complete platform that covers training, community, content and fandom like no other.

    For more information, visit www.mma.inc

    Disclaimer

    As we continue to develop our plans discussed above, they could change and there can be no assurance as to any final outcome.

    The information provided in this press release is intended for informational purposes only and does not constitute investment advice, endorsement, analysis, or recommendations with respect to any financial instruments, investments, or issuers. This press release does not take into account the investment objectives, financial situation, or specific needs of any particular person and each individual is urged to consult their legal and financial advisors before making any investment decisions.

    Forward-Looking Statements

    This press release contains forward-looking statements. Any statements contained herein regarding our strategy, platform development, future operations, financial position, future revenues, projected costs, prospects, plans and objectives of management, other than statements of historical facts, are forward-looking statements. The forward-looking statements included herein include or may include, but are not limited to, statements that are predictive in nature, depend upon or refer to future events or conditions, or use or contain words, terms, phrases, or expressions such as “achieve,” “forecast,” “plan,” “propose,” “strategy,” “envision,” “hope,” “will,” “continue,” “potential,” “expect,” “believe,” “anticipate,” “project,” “estimate,” “predict,” “intend,” “should,” “could,” “may,” “might,” or similar words, terms, phrases, or expressions or the negative of any of these terms. Any statements contained in this press release that are not based upon historical fact are based on current expectations, estimates, projections, opinions and/or beliefs of the Company. Such statements are not facts and involve known and unknown risks, uncertainties, and other factors. Prospective investors should not rely on these statements as if they were facts. Actual revenue may vary to current sales due to factors such as participant churn, cancellations, and changes in payment schedules, membership terms or pricing changes. Any references to verified gyms, partner gyms, user profiles refer to a database profile that has been claimed or created across the MMA.INC platform, which includes TrainAlta.com, BJJ Link, Hype, MixedMartialArts.com and Steppen. Forward-looking statements involve a number of known and unknown risks and uncertainties, including, but not limited to, those discussed in the “Risk Factors” section of the Form 20-F for the fiscal year ended June 30, 2025 filed with the SEC. Given the risks and uncertainties, readers should not place undue reliance on any forward-looking statement and should recognize that the statements are predictions of future results which may not occur as anticipated. New risk factors emerge from time to time, and it is not possible for management to predict all such risk factors, nor can it assess the impact of all such factors on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. You should carefully read the factors described in the “Risk Factors” section of the Form 20-F for the fiscal year ended June 30, 2025 filed with the SEC to better understand the risks and uncertainties inherent in our business and industry, and any underlying forward-looking statements. Except where required by law, the Company assumes no obligation to update, withdraw or revise any forward-looking statements to reflect actual results or changes in factors or assumptions affecting such forward-looking statements.

    Media Contacts

    Mixed Martial Arts Group Limited
    E: [email protected]


    Read Full Article
    Press Release: Congressman Morgan Griffith Highlights Health Care Awareness Efforts in March Recap
    49 minutes ago | April 1, 2026 2:21 p.m. UTC

    Chairman Griffith addressed health care issues and promoted affordability initiatives during March, highlighting solutions for rural access.

    Quiver AI Summary

    Congressman Griffith highlights health care initiatives: U.S. Congressman Morgan Griffith (R-VA), Chairman of the Health Subcommittee, has been actively addressing health care issues through a series of hearings aimed at lowering costs. His proposed legislation, the Physician-Led and Rural Access to Quality Care Act, aims to enhance patient access to care.

    Focus on rural health and community resources: Griffith also discussed rural health care on The Julie Mason Show, emphasizing his op-ed about federal investments in community health and telehealth initiatives. His remarks further acknowledge contributions of community health centers in supporting rural areas.

    Advocating for awareness and legislation: Additionally, Griffith has engaged in health-related causes, wearing a turquoise ribbon for Lung Cancer Awareness Day and sponsoring the Lung Cancer Screening and Prevention Act. He submitted remarks for National Area Health Education Centers Week to support critical health care needs in Virginia's Ninth District.

    Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

    Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

    🏛️ Receive Alerts on Congress
    Sign Up

    H. Morgan Griffith Fundraising

    H. Morgan Griffith Fundraising

    H. Morgan Griffith recently disclosed $199.5K of fundraising in a Q4 FEC disclosure filed on January 31st, 2026. This was the 488th most from all Q4 reports we have seen this year. 33.8% came from individual donors.

    Griffith disclosed $208.6K of spending. This was the 355th most from all Q4 reports we have seen from politicians so far this year.

    Griffith disclosed $698.8K of cash on hand at the end of the filing period. This was the 494th most from all Q4 reports we have seen this year.

    You can see the disclosure here, or track H. Morgan Griffith's fundraising on Quiver Quantitative.

    H. Morgan Griffith Net Worth

    Quiver Quantitative estimates that H. Morgan Griffith is worth $665.5K, as of April 1st, 2026. This is the 369th highest net worth in Congress, per our live estimates.

    Griffith has approximately $0 invested in publicly traded assets which Quiver is able to track live.

    You can track H. Morgan Griffith's net worth on Quiver Quantitative's politician page for Griffith.

    H. Morgan Griffith Bill Proposals

    Here are some bills which have recently been proposed by H. Morgan Griffith:

    • H.R.7614: To direct the Architect of the Capitol to install an adult changing room in the Library of Congress and the Capitol Visitor Center.
    • H.R.7212: To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of cannabinoid hemp products, and for other purposes.
    • H.R.7211: To authorize the President to award the Medal of Honor to John W. Ripley for acts of valor during the Vietnam War, and for other purposes.
    • H.R.6028: Legislative Branch Agencies Clarification Act
    • H.R.5736: PAVE Act
    • H.R.5549: Efficient Nuclear Licensing Hearings Act

    You can track bills proposed by H. Morgan Griffith on Quiver Quantitative's politician page for Griffith.

    2026 Virginia's 9th Congressional District Election

    There has been approximately $1,925,179 of spending in Virginia's 9th congressional district elections over the last two years, per our estimates.

    The rating for this race is currently "Solid R".

    You can track this election on our matchup page for the 2026 Virginia's 9th congressional district election.

    Read Full Article
    Meta Platforms Stock (META) Opinions on Court Ruling Pullback
    an hour ago | April 1, 2026 2:03 p.m. UTC

    Court ruling fallout: Social media erupted following a landmark court decision holding Meta Platforms accountable for inadequate safeguards for young users, erasing over $100 billion in market value and driving shares down more than 7% in a single session. The stock has declined over 20% year-to-date, amplifying concerns around ongoing litigation in key regions.

    Valuation appeal amid pullback: Discussions highlighted the shares trading at a forward P/E below 20 with anticipated 30% year-over-year revenue growth, positioning it as a potential value opportunity compared to peers. Investors noted robust margins and unmonetized assets like Threads, despite worries over hefty AI capital expenditures exceeding $135 billion.

    Emerging rebound signals: Chatter picked up on new Ray-Ban prescription smart glasses launching soon, fueling a sharp intraday rally as traders eyed fresh catalysts. With earnings approaching, focus remains on accelerating ad revenue and AI infrastructure advantages to counter recent headwinds like geopolitical threats.

    Note: This discussion summary was generated from an AI condensation of post data.

    Meta Platforms Insider Trading Activity

    META Insider Trades

    Meta Platforms insiders have traded $META stock on the open market 108 times in the past 6 months. Of those trades, 0 have been purchases and 108 have been sales.

    Here’s a breakdown of recent trading of $META stock by insiders over the last 6 months:

    • SUSAN J LI (Chief Financial Officer) has made 0 purchases and 24 sales selling 144,355 shares for an estimated $92,273,250.
    • ANDREW BOSWORTH (Chief Technology Officer) has made 0 purchases and 11 sales selling 24,842 shares for an estimated $15,127,520.
    • JAVIER OLIVAN (Chief Operating Officer) has made 0 purchases and 51 sales selling 23,470 shares for an estimated $15,112,363.
    • JENNIFER NEWSTEAD (Chief Legal Officer) has made 0 purchases and 13 sales selling 6,744 shares for an estimated $4,490,892.
    • ROBERT M KIMMITT has made 0 purchases and 6 sales selling 3,385 shares for an estimated $2,169,579.
    • PEGGY ALFORD has made 0 purchases and 2 sales selling 993 shares for an estimated $657,370.
    • AARON ANDERSON (Chief Accounting Officer) sold 726 shares for an estimated $429,501

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

    Meta Platforms Revenue

    META Quarterly Revenue

    Meta Platforms had revenues of $51.2B in Q3 2025. This is an increase of 26.25% from the same period in the prior year.

    You can track META financials on Quiver Quantitative's META stock page.

    Meta Platforms Congressional Stock Trading

    Members of Congress have traded $META stock 16 times in the past 6 months. Of those trades, 10 have been purchases and 6 have been sales.

    Here’s a breakdown of recent trading of $META stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

    Meta Platforms Hedge Fund Activity

    We have seen 2,602 institutional investors add shares of Meta Platforms stock to their portfolio, and 1,885 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    Meta Platforms Analyst Ratings

    Wall Street analysts have issued reports on $META in the last several months. We have seen 22 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Argus Research issued a "Buy" rating on 02/02/2026
    • DA Davidson issued a "Buy" rating on 01/29/2026
    • Morgan Stanley issued a "Overweight" rating on 01/29/2026
    • Mizuho issued a "Outperform" rating on 01/29/2026
    • Stifel issued a "Buy" rating on 01/29/2026
    • Truist Securities issued a "Buy" rating on 01/29/2026
    • B of A Securities issued a "Buy" rating on 01/29/2026

    To track analyst ratings and price targets for Meta Platforms, check out Quiver Quantitative's $META forecast page.

    Meta Platforms Price Targets

    Multiple analysts have issued price targets for $META recently. We have seen 32 analysts offer price targets for $META in the last 6 months, with a median target of $850.0.

    Here are some recent targets:

    • Brian Nowak from Morgan Stanley set a target price of $775.0 on 03/30/2026
    • Ivan Feinseth from Tigress Financial set a target price of $945.0 on 03/18/2026
    • Ken Gawrelski from Wells Fargo set a target price of $856.0 on 02/23/2026
    • Joseph Bonner from Argus Research set a target price of $800.0 on 02/02/2026
    • Thomas Champion from Piper Sandler set a target price of $880.0 on 01/29/2026
    • Justin Post from B of A Securities set a target price of $885.0 on 01/29/2026
    • Youssef Squali from Truist Securities set a target price of $900.0 on 01/29/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Read Full Article
    Huize Holding Stock (HUIZ) Opinions on CEO Open-Market Purchase
    an hour ago | April 1, 2026 2:03 p.m. UTC

    CEO Insider Buy Sparks Interest: Social media discussions on Huize Holding stock (HUIZ) have recently focused on a notable open-market purchase by the chief executive officer, amounting to over $109,000. This transaction, reported without a pre-arranged 10b5-1 plan, has caught the attention of investors tracking insider activity as a potential indicator of confidence in the company's future performance.

    Limited but Positive Chatter: While overall volume of conversation remains low, the insider buy has generated optimistic commentary among followers of stock filings. Participants highlighted the timing and size of the purchase amid broader market volatility, viewing it as a bullish signal from leadership.

    Investor Watch: Traders on social media are monitoring for further developments, with some speculating on upcoming catalysts for HUIZ shares. The sentiment leans toward cautious optimism, driven primarily by this executive's commitment to the stock.

    Note: This discussion summary was generated from an AI condensation of post data.

    Huize Holding Insider Trading Activity

    HUIZ Insider Trades

    Huize Holding insiders have traded $HUIZ stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

    Here’s a breakdown of recent trading of $HUIZ stock by insiders over the last 6 months:

    • CUNJUN MA (Chief Executive Officer) has made 3 purchases buying 7,842,032 shares for an estimated $113,976 and 0 sales.

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

    Huize Holding Hedge Fund Activity

    We have seen 5 institutional investors add shares of Huize Holding stock to their portfolio, and 2 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Read Full Article
    Caterpillar Inc. Stock (CAT) Opinions on Quarterly Earnings
    an hour ago | April 1, 2026 2:03 p.m. UTC

    Earnings margins in focus: Social media discussions highlight Caterpillar's recent quarterly results, with revenue climbing 4% to $67.6 billion yet operating income dropping 15% amid margin compression to 16.5%. Investors note the mixed signals, praising revenue growth while cautioning on profitability pressures from costs and pricing.

    Backlog bolsters outlook: Chatter emphasizes the firm's $50 billion order backlog as a key strength, signaling robust demand across 190 countries and opportunities in autonomous mining. Many view the industrial giant's global footprint and steady cash flow as foundations for long-term resilience despite short-term squeezes.

    Q1 gains amid pullback: The stock's 23% rise in the first quarter outperformed a declining S&P 500, drawing praise as a top pick, though recent dips to around $697 have some calling it a buying opportunity. Sentiment reflects optimism on fundamentals tempered by market volatility.

    Note: This discussion summary was generated from an AI condensation of post data.

    Caterpillar Inc. Insider Trading Activity

    CAT Insider Trades

    Caterpillar Inc. insiders have traded $CAT stock on the open market 58 times in the past 6 months. Of those trades, 1 have been purchases and 57 have been sales.

    Here’s a breakdown of recent trading of $CAT stock by insiders over the last 6 months:

    • LANGE BOB DE (Group President) has made 0 purchases and 7 sales selling 81,848 shares for an estimated $56,381,449.
    • DENISE C JOHNSON (Group President) has made 0 purchases and 8 sales selling 39,138 shares for an estimated $26,655,960.
    • ANTHONY D. FASSINO (Group President) has made 0 purchases and 4 sales selling 32,779 shares for an estimated $22,414,683.
    • ANDREW R J BONFIELD (Chief Financial Officer) has made 0 purchases and 14 sales selling 20,000 shares for an estimated $11,465,037.
    • III DONALD J UMPLEBY (Executive Chairman) sold 17,166 shares for an estimated $8,673,808
    • JASON KAISER (Group President) has made 0 purchases and 14 sales selling 12,397 shares for an estimated $7,347,113.
    • RODNEY MICHAEL SHURMAN (Group President) has made 0 purchases and 2 sales selling 4,042 shares for an estimated $3,077,011.
    • JOSEPH E CREED (Chief Executive Officer) has made 0 purchases and 5 sales selling 2,500 shares for an estimated $1,797,316.
    • WILLIAM E SCHAUPP (Chief Accounting Officer) has made 0 purchases and 2 sales selling 2,172 shares for an estimated $1,429,466.
    • DAVID MACLENNAN purchased 300 shares for an estimated $170,658

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

    Caterpillar Inc. Revenue

    CAT Quarterly Revenue

    Caterpillar Inc. had revenues of $19.1B in Q4 2025. This is an increase of 18.0% from the same period in the prior year.

    You can track CAT financials on Quiver Quantitative's CAT stock page.

    Caterpillar Inc. Congressional Stock Trading

    Members of Congress have traded $CAT stock 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.

    Here’s a breakdown of recent trading of $CAT stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

    Caterpillar Inc. Hedge Fund Activity

    We have seen 1,504 institutional investors add shares of Caterpillar Inc. stock to their portfolio, and 1,382 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    Caterpillar Inc. Government Contracts

    We have seen $280,406,515 of award payments to $CAT over the last year.

    Here are some of the awards which we have have seen pay out the most over the last year:

    To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

    Caterpillar Inc. Analyst Ratings

    Wall Street analysts have issued reports on $CAT in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Wells Fargo issued a "Overweight" rating on 01/30/2026
    • Jefferies issued a "Buy" rating on 01/30/2026
    • JP Morgan issued a "Overweight" rating on 01/30/2026
    • Citigroup issued a "Buy" rating on 01/13/2026
    • Morgan Stanley issued a "Underweight" rating on 10/30/2025
    • Truist Securities issued a "Buy" rating on 10/30/2025
    • B of A Securities issued a "Buy" rating on 10/15/2025

    To track analyst ratings and price targets for Caterpillar Inc., check out Quiver Quantitative's $CAT forecast page.

    Caterpillar Inc. Price Targets

    Multiple analysts have issued price targets for $CAT recently. We have seen 15 analysts offer price targets for $CAT in the last 6 months, with a median target of $765.0.

    Here are some recent targets:

    • Kyle Menges from Citigroup set a target price of $785.0 on 03/09/2026
    • Kristen Owen from Oppenheimer set a target price of $817.0 on 03/06/2026
    • Jerry Revich from Wells Fargo set a target price of $870.0 on 02/25/2026
    • David Raso from Evercore ISI Group set a target price of $878.0 on 02/23/2026
    • Michael Feniger from B of A Securities set a target price of $825.0 on 02/10/2026
    • Angel Castillo from Morgan Stanley set a target price of $425.0 on 02/03/2026
    • Jamie Cook from Truist Securities set a target price of $786.0 on 02/02/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Read Full Article
    Sidus Space Inc. (SIDU) Stock Falls on Q4 2025 Earnings
    an hour ago | April 1, 2026 1:47 p.m. UTC

    Sidus Space Inc. (SIDU) reported fourth-quarter 2025 results showing revenue of $586,303, down 29.0% year-over-year.

  • Gross loss of -$1.74 million (year-over-year change +131.7%).
  • Operating loss of -$11.01 million (year-over-year change +116.5%).
  • Net loss attributable to common shareholders of -$11.40 million (year-over-year change +100.9%).
  • Diluted loss per share of -$0.31 (improved 19.2% year-over-year).

    • Cash flow and balance sheet highlights:

  • Cash used in operating activities of -$4.09 million (down 26.2% year-over-year).
  • Purchases of property, plant and equipment of -$2.38 million (year-over-year change +0.5%).
  • Cash and cash equivalents of $43.2 million (up 174.9% year-over-year).
  • Total liabilities of $15.46 million (up 8.8% year-over-year).

    • Additional operating detail: cost of sales was $2.32 million (year-over-year change +47.5%).

  • Stock price change since market open this morning: -1.08%.

    • Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

    Sidus Space Inc. Hedge Fund Activity

    We have seen 40 institutional investors add shares of Sidus Space Inc. stock to their portfolio, and 5 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • HRT FINANCIAL LP added 1,364,142 shares (+inf%) to their portfolio in Q4 2025, for an estimated $4,283,405
    • JANE STREET GROUP, LLC added 719,196 shares (+2970.3%) to their portfolio in Q4 2025, for an estimated $2,258,275
    • VANGUARD GROUP INC added 704,823 shares (+125.3%) to their portfolio in Q4 2025, for an estimated $2,213,144
    • UBS GROUP AG added 497,180 shares (+27332.6%) to their portfolio in Q4 2025, for an estimated $1,561,145
    • XTX TOPCO LTD added 495,266 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,555,135
    • SCIENTECH RESEARCH LLC added 289,382 shares (+inf%) to their portfolio in Q4 2025, for an estimated $908,659
    • SASSICAIA CAPITAL ADVISERS LLC added 201,514 shares (+inf%) to their portfolio in Q4 2025, for an estimated $632,753

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    Read Full Article
    CarMax Recognized as One of the 100 Best Companies to Work For® for the 22nd Consecutive Year
    an hour ago | April 1, 2026 1:40 p.m. UTC

    CarMax is honored as one of the 100 Best Companies to Work For® in 2026 by Fortune and Great Place to Work®.

    Quiver AI Summary

    CarMax has been named one of the 100 Best Companies to Work For® by Fortune Media and Great Place to Work® for the 22nd consecutive year, ranking #56 for 2026. This recognition highlights CarMax's strong workplace culture, as reflected in employee survey responses analyzed by Great Place to Work, which underscores the importance of trust in organizational performance. CarMax, the largest used car retailer in the U.S., also received other accolades over the past year, such as being recognized as one of the Best Workplaces in Retail and for Parents. The company is actively hiring for various positions across its business and offers competitive pay, comprehensive benefits, and a commitment to community and environmental responsibility. Interested applicants can find job openings on CarMax's careers website.

    Potential Positives

    • CarMax has been recognized as one of the 100 Best Companies to Work For® for 2026, marking the 22nd consecutive year on this prestigious list, which emphasizes the company's commitment to employee satisfaction and workplace culture.
    • The company ranked #56 in the 2026 list, reinforcing its positive reputation in the competitive retail environment and potentially attracting new talent and customers.
    • CarMax's Chief Human Resources Officer highlighted the culture of trust and support among associates, which can lead to better employee engagement and performance, ultimately benefiting the company’s overall business outcomes.
    • In addition to the main recognition, CarMax received multiple accolades over the past year, including “Best Workplaces in Retail” and “Military Friendly Employer,” enhancing its brand image and appeal to diverse workforce segments.

    Potential Negatives

    • Despite being named one of the 100 Best Companies to Work For for 22 consecutive years, CarMax ranked lower at #56 in 2026 compared to previous years, which may indicate a decline in employee satisfaction or a more competitive environment.
    • The reliance on survey responses from employees to secure rankings may expose CarMax to potential criticisms regarding how representative or comprehensive employee sentiment truly is.
    • The emphasis on numerous job openings might suggest that the company is experiencing workforce turnover issues or gaps that they are struggling to fill.

    FAQ

    What recognition did CarMax receive in 2026?

    CarMax was recognized as one of the 100 Best Companies to Work For® by Fortune Media and Great Place to Work® in 2026.

    How many years has CarMax been on the Best Companies list?

    This marks the 22nd consecutive year that CarMax has been named to the prestigious Best Companies to Work For® list.

    What is the ranking of CarMax in 2026?

    In 2026, CarMax ranked #56 on the Fortune 100 Best Companies to Work For® list.

    How are the Best Companies to Work For® selected?

    Selection is based on anonymous survey responses from over 1.3 million U.S. employees analyzed by Great Place to Work Certified™.

    What job openings are available at CarMax?

    CarMax has various job openings including roles in sales, auto technicians, business office associates, and customer specialists.

    Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.


    $KMX Insider Trading Activity

    KMX Insider Trades

    $KMX insiders have traded $KMX stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

    Here’s a breakdown of recent trading of $KMX stock by insiders over the last 6 months:

    • MARK F ONEIL purchased 10,816 shares for an estimated $499,807
    • MITCHELL D STEENROD purchased 2,000 shares for an estimated $91,140

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

    $KMX Hedge Fund Activity

    We have seen 249 institutional investors add shares of $KMX stock to their portfolio, and 397 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    $KMX Analyst Ratings

    Wall Street analysts have issued reports on $KMX in the last several months. We have seen 0 firms issue buy ratings on the stock, and 3 firms issue sell ratings.

    Here are some recent analyst ratings:

    • B of A Securities issued a "Underperform" rating on 12/19/2025
    • Barclays issued a "Underweight" rating on 12/19/2025
    • JP Morgan issued a "Underweight" rating on 12/19/2025

    To track analyst ratings and price targets for $KMX, check out Quiver Quantitative's $KMX forecast page.

    $KMX Price Targets

    Multiple analysts have issued price targets for $KMX recently. We have seen 12 analysts offer price targets for $KMX in the last 6 months, with a median target of $36.0.

    Here are some recent targets:

    • Michael Montani from Evercore ISI Group set a target price of $39.0 on 03/17/2026
    • Craig Kennison from Baird set a target price of $48.0 on 02/18/2026
    • John Babcock from Barclays set a target price of $28.0 on 01/21/2026
    • Rajat Gupta from JP Morgan set a target price of $28.0 on 12/19/2025
    • John Murphy from B of A Securities set a target price of $31.0 on 12/19/2025
    • Scot Ciccarelli from Truist Securities set a target price of $37.0 on 12/19/2025
    • Steven Shemesh from RBC Capital set a target price of $37.0 on 12/19/2025

    Full Release

    RICHMOND, Virginia, April 01, 2026 (GLOBE NEWSWIRE) -- Fortune Media and Great Place to Work® have recognized CarMax (NYSE: KMX) as one of the 100 Best Companies to Work For® in 2026. This marks the 22 nd consecutive year that CarMax has been named to this prestigious list, which annually recognizes the best companies to work for in the country. CarMax , the nation’s largest retailer of used cars , ranks #56 for 2026.

    “Congratulations to CarMax associates for this recognition, which reflects the culture you’ve built and strengthened over time,” said Craig Cronheim, CarMax’s Chief Human Resources Officer. “I’m grateful for the trust, care, and support you show one another, our customers, and communities every day.”

    The Fortune 100 Best Companies to Work For ® award is highly competitive and is the only recognition that focuses on how employees feel about their workplace. To determine the list, Great Place to Work Certified™ analyzed the anonymous survey responses of more than 1.3 million U.S. employees. Only companies with consistently high survey responses across the 60 statements that comprise the Trust Index™ Survey earn placement on the exclusive list.

    “Trust in the organization is a leading indicator of business performance,” says Michael C. Bush, CEO of Great Place To Work. “When employees trust their leaders, they are more willing to give extra effort, embrace innovation, and deliver a better experience to customers.”

    Additional recognitions over the last year for CarMax include Fortune’s “ Best Workplaces in Retail ;” Fortune’s “ Best Workplaces for Parents ;” PEOPLE’s “ Companies that Care ;” and recognition by Military Friendly as a “ Military Friendly Employer .”

    CarMax currently has job openings across several areas of its business. Positions range from full- to part-time, with day and evening shifts available. Some of the current open positions include roles such as auto technicians and automotive service professionals, sales, business office associates and customer specialists. Jobs are also available at CarMax’s corporate locations, including technology, strategy, and data science roles. Interested candidates can visit careers.carmax.com to apply.

    CarMax is proud to provide competitive pay and benefits, including:

    • Discounts on car purchases, which can be extended to family members – including spouses, parents, grandparents, siblings and children.
    • Immediate 401(k) eligibility with an industry-leading 6% match on eligible contributions.
    • Wellness benefits such as gym discounts and free access to Headspace, which provides guided meditation and mindfulness that can support overall well-being and better sleep.
    • Paid time off, comprehensive medical plan, tuition reimbursement, adoption assistance, employee stock purchase plan, and more.

    # # #

    About CarMax
    CarMax, the nation’s largest retailer of used autos, revolutionized the automotive retail industry by driving integrity, honesty and transparency in every interaction. The company offers a truly personalized experience with the option for customers to do as much, or as little, online and in-store as they want. During the fiscal year that ended February 28, 2025, CarMax sold approximately 790,000 used vehicles and 540,000 wholesale vehicles at its auctions. In addition, CarMax Auto Finance originated more than $8 billion in auto loans during fiscal 2025, adding to its nearly $18 billion portfolio. CarMax has more than 250 store locations, over 28,000 associates, and is proud to have been recognized for 22 consecutive years as one of the Fortune 100 Best Companies to Work For®. CarMax is committed to helping its communities thrive and reducing the environmental footprint of its operations. Learn more in the 2025 Responsibility Report . For more information, visit www.carmax.com . 

    
 
    

    

    
                
    
              
    
            
    
          
    
          
          
    
            
              
            
          
    
          
          
            
          
            Read Full Article
        
    
      
    
    
      
    
        
    
          
    
            IP Strategy Holdings, Inc. Supports Verse8's AI Game Creation Revolution with $5 Million Seed Funding Round
            
    
              an hour ago | April 1, 2026 1:30 p.m. UTC
              
    
                
    
                  
    IP Strategy Holdings announces $5 million seed funding for Verse8, an AI platform for creating multiplayer games with text prompts.
    Quiver AI Summary
    IP Strategy Holdings, Inc. announced a successful $5 million seed funding round for Verse8, an innovative AI-powered platform that enables creators to develop playable multiplayer games through natural language prompts. Supported by Story Foundation and various gaming and tech investors, the funding aims to enhance Verse8's AI-driven game creation systems and expand its creator ecosystem. With the global video game market valued at $239.92 billion in 2025 and a growing user base, Verse8 has rapidly attracted over 3.5 million monthly active users and supports thousands of creators and games. The platform is designed to simplify game development, eliminating the need for extensive resources while integrating features for licensing and ownership rights within a blockchain framework. IP Strategy Holdings, which operates a validator for the Story Protocol and holds $IP tokens, emphasizes the potential of AI-native tools in transforming interactive media into a scalable asset class.
    Potential Positives
    • IP Strategy Holdings, Inc. successfully completed a $5 million seed funding round for Verse8, indicating strong investor confidence and potential for growth in the AI-driven game development sector.
    • Verse8 has rapidly gained traction with over 3.5 million monthly active users and 5,000 creators, showcasing its popularity and effectiveness in democratizing game creation.
    • The platform's integration with Story facilitates on-chain ownership and monetization of creator-generated content, enhancing its value proposition in the gaming industry.
    • This funding and growth of Verse8 align with the burgeoning $239.92 billion global video game market, positioning IP Strategy for significant opportunities in the expanding creator economy.
    Potential Negatives
    • The press release contains numerous forward-looking statements, indicating potential instability due to uncertainties and risks associated with the company's projections and market expectations.
    • The reliance on $IP tokens as a primary reserve asset may expose the company to significant volatility and financial risk, particularly given the legal and regulatory uncertainties surrounding digital assets.
    • The highlight of financing for Verse8 may raise concerns about IP Strategy's dependency on external funding for development and growth, which could affect long-term sustainability if funding is not secured in the future.
    FAQ
    What is Verse8?
    Verse8 is an AI-native platform that enables creators to generate playable multiplayer games using natural language prompts.
    Who backed the recent funding for Verse8?
    The $5 million seed funding round for Verse8 was backed by Story Foundation and various gaming and technology investors.
    How does Verse8 benefit game creators?
    Verse8 allows creators to quickly transform ideas into games without the need for complex engines or large development teams.
    What is the significance of the global video game market?
    The global video game market was valued at $239.92 billion in 2025, presenting opportunities for creator-driven tools like Verse8.
    How does IP Strategy Holdings relate to programmable intellectual property?
    IP Strategy Holdings is a Nasdaq-listed company that offers exposure to the programmable intellectual property economy through its $IP tokens.
    Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

    $IPST Hedge Fund Activity
    We have seen 8 institutional investors add shares of $IPST stock to their portfolio, and 10 decrease their positions in their most recent quarter.
    Here are some of the largest recent moves:
    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
    Full Release
    
 
    
  GIG HARBOR, Wash., April  01, 2026  (GLOBE NEWSWIRE) -- IP Strategy Holdings, Inc. (Nasdaq: IPST) today highlighted the recent $5 million seed funding round for Verse8, an AI-native platform enabling creators to generate fully playable multiplayer games using natural language prompts.
 
    
 
    
  The round was backed by Story Foundation and a consortium of gaming and technology investors including, NEXPACE, Neowiz, MARBLEX, Solarium Labs, and NEXUS. The financing is expected to support continued development of Verse8’s AI-driven game creation systems and expansion of its creator ecosystem.
 
    
 
    
  The milestone comes as the global video game market was valued at $239.92 billion in 2025 with 3.6 billion players worldwide creating a massive opportunity for new creator-driven tools that dramatically reduce the cost and complexity of building interactive experiences.
  
   1
  
  
   2
  
 
    
 
    
  Verse8 allows creators to instantly transform ideas into playable multiplayer experiences using simple text prompts, eliminating the need for complex engines, large development teams, or lengthy production cycles. Since launch, the platform has grown rapidly, reaching more than 3.5 million monthly active users, supporting 5,000 creators, and enabling the creation of over 25,000 games.
 
    
 
    
  As generative AI lowers the barriers to creative production across video, music, and images, interactive media represents one of the largest remaining frontiers for creator-led AI tools.
 
    
 
    
  The platform is integrated with Story to provide onchain ownership, licensing, and distribution for creator-generated content. This allows game creators to retain attribution, participate in downstream revenue, and safely remix existing intellectual property within programmable licensing frameworks.
 
    
 
    
  From IP Strategy’s perspective, Verse8 demonstrates how AI-native creation tools can transform interactive media into a scalable, creator-owned asset class within a programmable IP ecosystem.
 
    
 
    
  IP Strategy expects to continue highlighting ecosystem developments that demonstrate real-world adoption, sustainable economic models, and long-term alignment with Story’s vision for programmable intellectual property.
 
    
 
    
  
   About IP Strategy
  
 
    
 
    
  IP Strategy Holdings, Inc. (Nasdaq: IPST) is the first Nasdaq-listed company to hold $IP tokens as a primary reserve asset and operate a validator for the Story Protocol. The Company provides public market investors broad exposure to the $80 trillion programmable intellectual property economy in a regulated equity format. IP Strategy’s treasury reserve of $IP tokens provides direct participation in the Story ecosystem, which enables on-chain registration, licensing, and monetization of intellectual property.
 
    
 
    
  
   About Story
  
 
    
 
    
  Story is the AI-native blockchain network powering the $IP token and making intellectual property programmable, traceable, and monetizable in real time. Backed by $136 million from a16z crypto, Polychain Capital, and Samsung Ventures, Story launched its mainnet in February 2025 and has rapidly become a leading infrastructure for tokenized intellectual property. Story allows creators and enterprises to turn media, data, and AI-generated content into legally enforceable digital assets with embedded rights, enabling automated licensing and new markets for intellectual property across AI and entertainment.
 
    
 
    
  
   Forward-Looking Statements
  
 
    
 
    
  This press release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as “aims,” “anticipates,” “believes,” “could,” “estimates,” “expects,” “forecasts,” “goal,” “intends,” “may,” “plans,” “possible,” “potential,” “seeks,” “will,” and variations of these words or similar expressions that are intended to identify forward-looking statements. Any such statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements. These forward-looking statements include, but are not limited to, the potential for the financing to support continued development of Verse8’s AI-driven game creation systems and expansion of its creator ecosystem, the potential growth of Verse8, and IP Strategy’s expectations to continue highlighting ecosystem developments that demonstrate real-world adoption, sustainable economic models, and long-term alignment with Story’s vision for programmable intellectual property.
 
    
 
    
  Any forward-looking statements in this press release are based on IP Strategy’s current expectations, estimates and projections only as of the date of this release and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, risks related to the volatility of the Company’s common stock and any correlation between the Company’s stock price and the price of $IP tokens or any correlation between the Company’s stock price and activity or projects within the Story ecosystem, the legal, commercial, regulatory and technical uncertainty regarding digital assets generally, and expectations with respect to future performance and growth. These and other risks concerning IP Strategy’s programs and operations are described in additional detail in its registration statement on Form S-1 initially filed with the Securities and Exchange Commission (“SEC”) on August 26, 2025, as amended by Amendment No. 1 filed on October 16, 2025, Amendment No. 2 filed on December 12, 2025 and Amendment No. 3 filed on December 19, 2025, its latest annual report on Form 10-K, subsequent quarterly reports on Form 10-Q, and any other subsequent filings with the SEC. IP Strategy explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.
 
    
 
    
  
   Investor Contact
  
  
    
  (800) 595-3550
  
    
  
   
    [email protected]
   
  
 
    
 
    
  _________________
  
    
  
   
    1
   
  
  
   
    https://newzoo.com/resources/trend-reports/newzoo-global-games-market-report-2025
   
  
  
    
  
   
    2
   
  
  
   
    https://www.fortunebusinessinsights.com/video-game-market-102548
   
  
 
    
 
    

    

    
                
    
              
    
            
    
          
    
          
          
    
            
              
            
          
    
          
          
            
          
            Read Full Article
        
    
      
    
    
      
    
        
    
          
    
            Progyny Marks 10 Years of Transforming Women's Health and Family Building Benefits
            
    
              an hour ago | April 1, 2026 1:30 p.m. UTC
              
    
                
    
                  
    Progyny celebrates ten years of transforming family building benefits, supporting millions through innovative women's health solutions.
    Quiver AI Summary
    Progyny, a leader in women’s health and family building solutions, announces its decade-long impact on improving access to essential benefits for millions. Throughout 2026, the company will celebrate this milestone by honoring the contributions of its members, partners, and employers who have supported its mission since its founding in 2016. Progyny has seen significant growth, expanding its services to over 600 employers and supporting over 470,000 members globally. The company has recorded impressive outcomes in fertility treatments, with higher pregnancy rates and reduced costs for members. Key events include partnerships with RESOLVE for National Infertility Awareness Week and initiatives like “Yeah, Baby Day.” Progyny aims to continue innovating in women's health and family-building benefits, striving for better care standards and patient outcomes.
    Potential Positives
    • Progyny celebrates its 10-year anniversary, highlighting significant growth from 5 founding employers to over 600, now covering 7.2 million lives globally.
    • The company boasts a nearly 100% client retention rate over the past decade, indicating strong satisfaction among employers and members.
    • Progyny leads in clinical outcomes, reporting 12% higher pregnancy rates per IVF transfer and 41% fewer egg retrievals per live birth compared to national averages.
    • Initiatives such as partnering with RESOLVE during National Infertility Awareness Week promote awareness and position Progyny as a leader in the conversation around infertility and family building solutions.
    Potential Negatives
    • The press release focuses predominantly on past achievements and future initiatives, which may suggest a lack of immediate, impactful new developments or products being launched, potentially indicating stagnation in innovation.
      •   

    • The emphasis on celebrating a decade of achievements might detract from addressing current challenges or criticisms the company may be facing, potentially raising concerns about transparency in their ongoing operations.
      •   

    • While Progyny highlights impressive client retention rates and positive outcomes, the absence of detailed statistics or comparisons to competitors could lead stakeholders to question the broader market positioning and effectiveness of their solutions.
    FAQ
    What is Progyny's role in women's health?
    Progyny is a global leader in women’s health and family building solutions, providing comprehensive benefits to support individuals and families.
    How long has Progyny been supporting families?
    Progyny has been supporting families for ten years, since its founding in 2016.
    What initiatives is Progyny celebrating for its 10-year anniversary?
    Progyny is celebrating with initiatives such as community events, lighting the Empire State Building, and participating in the NASDAQ Closing Bell Ceremony.
    What impact has Progyny had on fertility success rates?
    Progyny delivers significantly higher pregnancy rates and lower egg retrievals per live birth compared to national averages, improving member experiences during treatment.
    Where can I find more information about Progyny?
    More information about Progyny and its anniversary activities is available on their official website, www.progyny.com.
    Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

    $PGNY Insider Trading Activity
    PGNY Insider Trades
    $PGNY insiders have traded $PGNY stock on the open market 10 times in the past 6 months. Of those trades, 1 have been purchases and 9 have been sales.
    Here’s a breakdown of recent trading of $PGNY stock by insiders over the last 6 months:
    • PETER ANEVSKI  (CHIEF EXECUTIVE OFFICER)  purchased 79,500 shares for an estimated $1,930,896
    • MARK S. LIVINGSTON  (CHIEF FINANCIAL OFFICER) has made 0 purchases and 3 sales selling 21,975 shares for an estimated $560,362.
    • ALLISON SWARTZ  (EVP, GC) has made 0 purchases and 6 sales selling 10,383 shares for an estimated $206,979.
    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
    $PGNY Revenue
    PGNY Quarterly Revenue
    $PGNY had revenues of $318.4M in Q4 2025. This is an increase of 6.69% from the same period in the prior year.
    You can track PGNY financials on Quiver Quantitative's PGNY stock page.
    $PGNY Hedge Fund Activity
    We have seen 142 institutional investors add shares of $PGNY stock to their portfolio, and 169 decrease their positions in their most recent quarter.
    Here are some of the largest recent moves:
    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
    $PGNY Analyst Ratings
    Wall Street analysts have issued reports on $PGNY in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
    Here are some recent analyst ratings:
    • Citizens issued a "Market Outperform" rating on 01/20/2026
    To track analyst ratings and price targets for $PGNY, check out Quiver Quantitative's $PGNY forecast page.
    $PGNY Price Targets
    Multiple analysts have issued price targets for $PGNY recently. We have seen 7 analysts offer price targets for $PGNY in the last 6 months, with a median target of $28.0.
    Here are some recent targets:
    • Glen Santangelo from Barclays set a target price of $23.0 on 03/20/2026
      •  
    • Richard Close from Canaccord Genuity set a target price of $19.0 on 03/11/2026
      •  
    • David Larsen from BTIG set a target price of $30.0 on 03/05/2026
      •  
    • Jailendra Singh from Truist Securities set a target price of $28.0 on 03/02/2026
      •  
    • Scott Schoenhaus from Keybanc set a target price of $28.0 on 03/02/2026
      •  
    • Constantine Davides from Citizens set a target price of $30.0 on 01/20/2026
      •  
    • Lisa Gill from JP Morgan set a target price of $26.0 on 11/11/2025
      •  
    Full Release
    
 
    
  NEW YORK, April  01, 2026  (GLOBE NEWSWIRE) -- Over the past ten years, millions of individuals and families have gained access to life-changing benefits through
  
   Progyny
  
  , a global leader in women’s health and family building solutions. Progyny today announces that throughout the year, it will honor the collective efforts of its members, employers, providers, and industry partners who have helped shape this decade of progress. The company has redefined what’s possible in the benefits industry by combining clinical expertise, innovation, and a personalized approach to support members at every stage, from preconception through menopause.
 
    
 
    
  “Ten years ago, we set out to transform family building benefit coverage at a time when support was limited and often out of reach,” said Pete Anevski, CEO, Progyny. “Today, we’re helping millions of people access the care and support they need across every stage of their health journey, from building the family of their dreams to navigating life’s biggest transitions; from preconception to pregnancy, parenting, and menopause. This ten-year milestone reflects what’s possible when employers, providers, and advocates come together to solve one of the biggest challenges in healthcare.”
 
    
 
    
  The company will mark the occasion with a series of initiatives throughout the year centered on community and sparking national conversation. One of the cornerstone events will be during National Infertility Awareness Week (April 19–25), when Progyny will partner with
  
   RESOLVE: The National Infertility and Family Building Association
  
  to light the Empire State Building in orange alongside infertility advocate and celebrity Whitney Port on April 20. Progyny, RESOLVE, leading employers, and industry advocates will also participate in the NASDAQ Closing Bell Ceremony on April 21, raising awareness for the millions of individuals navigating infertility and family building journeys.
 
    
 
    
  Progyny kicked off the anniversary with “
  
   Yeah, Baby Day,
  
  ” an annual event launched on March 25, 2026, to celebrate each person's milestones, highlighting the moments where support can make all the difference.
 
    
 
    
  
   A Decade of Partnership, Impact, and Innovation
  
 
    
 
    
  Since entering the market in 2016, Progyny has supported over 470,000 members and expanded from 5 founding employers to more than 600 employers, covering 7.2 million lives. The company has also grown its global benefits solution to serve employees in over 100 countries, while broadening care across preconception, pregnancy, leave and benefits navigation, postpartum care, parenting, and menopause services. This level of exceptional care delivery has led to significant cost savings for employers and members, and a nearly 100% client retention rate over the past ten years.
 
    
 
    
  “It’s one of our most valued benefits because of the meaningful impact it’s had on so many of our employees’ lives,” said Lisa Wywoda, Head of Total Rewards at Unilever. “Over the past ten years, we’ve been able to support employees across the full journey — from early family planning and egg freezing through IVF — in a way that feels seamless and centered around our needs.”
 
    
 
    
  This level of expertise and clinical integration has also enabled Progyny to build one of the largest fertility data sets, showing that the company delivers 12% higher pregnancy rates per IVF transfer, 41% fewer egg retrievals per live birth, 23% higher live birth rates, and more than four times faster access to menopause care compared to the national average. These superior outcomes lead to a significantly better experience for members and their families during difficult times.
 
    
 
    
  “When we found out we had fertility coverage through Progyny, it felt like a whole new door opened for us,” said Erin Antoniak, Progyny member. “Fertility treatment can be incredibly expensive, and having that support allowed us to move forward with the care we needed during a really uncertain time.”
 
    
 
    
  Over the years, Progyny has helped lead the transformation of women’s health and family building benefits by being the first to introduce a fully inclusive definition of infertility, now recognized by ASRM, and first to offer a fully managed benefits solution with integrated clinical oversight, pharmacy support, and rigorous provider inclusion and credentialing standards. With 10 years of groundbreaking work behind it, Progyny is only just getting started. The company plans to continue to invest in new technologies, work with leading providers to advance clinical innovation, and shape national conversations to raise the standard of care across women’s health.
 
    
 
    
  For more information on Progyny’s 10-year anniversary activities, visit
  
   10 years of Progyny
  
  .
 
    
 
    
  
   About Progyny
  
 
    
 
    
  Progyny (Nasdaq: PGNY) is a global leader in women’s health and family building solutions, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients and physicians.
 
    
 
    
  Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
 
    
 
    
  Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit
  
   www.progyny.com
  
  .
 
    
 
    
  
   For Further Information, Please Contact:
  
 
    
 
    
  Media:
  
    
  Alexis Ford
  
    
  
   [email protected]
  
 
    
 
    
  Investors:
  
    
  James Hart
  
    
  
   [email protected]
  
 
    
 
    

    

    
                
    
              
    
            
    
          
    
          
          
    
            
              
            
          
    
          
          
            
          
            Read Full Article
        
    
      
    
    
      
    
        
    
          
    
            Lands’ End, Inc. Announces $100 Million Share Repurchase Program Authorized by Board of Directors
            
    
              an hour ago | April 1, 2026 1:22 p.m. UTC
              
    
                
    
                  
    Lands’ End announces a $100 million stock repurchase program over three years to enhance shareholder value.
    Quiver AI Summary
    Lands' End, Inc. announced that its Board of Directors has approved a share repurchase program allowing for the buyback of up to $100 million of its common stock from April 1, 2026, to March 31, 2029. The purchases may take place in various ways, including open market transactions, and are intended to enhance shareholder value as the company emphasizes its strategic direction. CFO Bernard McCracken highlighted the company's improved financial position following a recent joint venture with WHP Global, which has reduced debt and interest expenses. The repurchases will be funded through existing cash, operational cash flow, and other financial resources, and may be subject to various factors such as market conditions and trading volume. The previous share repurchase program concluded with the buyback of 1.26 million shares for $16 million.
    Potential Positives
    • The Board of Directors authorized a significant share repurchase program of up to $100 million, indicating strong confidence in the company's future and commitment to enhancing shareholder value.
    • The company improved its balance sheet by repaying its term loan debt in full, reducing interest expenses and providing greater financial flexibility.
    • The funding for the share repurchase will come from several sources, including operational cash flow and joint venture distributions, which showcases the company's solid financial position.
    • The previous share repurchase program demonstrated successful execution with the buyback of 1.26 million shares for $16 million, which supports the effectiveness of the current program.
    Potential Negatives
    • The share repurchase program may be suspended or discontinued at any time, creating uncertainty about the company's commitment to returning capital to shareholders.
    • There are significant risks cited related to global supply chain challenges and their potential impact on operations, which could affect the company's ability to meet customer demand.
    • The company acknowledges various forward-looking risks, including the dependence on third parties and the potential for significant volatility in the market price of its common stock, which may affect investor confidence.
    FAQ
    What is the purpose of Lands' End's share repurchase program?
    The program aims to enhance shareholder value by repurchasing up to $100 million of common stock.
    How long will the share repurchase program last?
    The program is authorized from April 1, 2026, through March 31, 2029.
    How will Lands' End fund the share repurchase?
    Purchases will be funded through existing cash, operations, joint venture distributions, or borrowings.
    What factors influence the timing of share repurchases?
    Factors include share price, availability, trading volume, and general market conditions.
    What were the results of the previous share repurchase program?
    Under the prior program, Lands' End repurchased 1.26 million shares for $16 million.
    Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

    $LE Revenue
    LE Quarterly Revenue
    $LE had revenues of $462.4M in Q4 2025. This is an increase of 4.69% from the same period in the prior year.
    You can track LE financials on Quiver Quantitative's LE stock page.
    $LE Hedge Fund Activity
    We have seen 43 institutional investors add shares of $LE stock to their portfolio, and 51 decrease their positions in their most recent quarter.
    Here are some of the largest recent moves:
    • BANK OF AMERICA CORP /DE/ added 394,260 shares (+2457.1%) to their portfolio in Q4 2025, for an estimated $5,724,655
    • BLACKROCK, INC. removed 137,070 shares (-13.6%) from their portfolio in Q4 2025, for an estimated $1,990,256
    • DIMENSIONAL FUND ADVISORS LP removed 117,815 shares (-9.1%) from their portfolio in Q4 2025, for an estimated $1,710,673
    • JANE STREET GROUP, LLC added 105,251 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,528,244
    • MARSHALL WACE, LLP added 73,443 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,066,392
    • O'SHAUGHNESSY ASSET MANAGEMENT, LLC added 59,487 shares (+150.4%) to their portfolio in Q4 2025, for an estimated $863,751
    • UBS GROUP AG removed 54,666 shares (-41.2%) from their portfolio in Q4 2025, for an estimated $793,750
    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
    $LE Analyst Ratings
    Wall Street analysts have issued reports on $LE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
    Here are some recent analyst ratings:
    • Small Cap Consumer Research issued a "Buy" rating on 12/18/2025
    To track analyst ratings and price targets for $LE, check out Quiver Quantitative's $LE forecast page.
    Full Release
    
 
    
  DODGEVILLE, Wis., April  01, 2026  (GLOBE NEWSWIRE) -- Lands’ End, Inc. (NASDAQ: LE) announced today that its Board of Directors has authorized the repurchase of up to $100 million of the Company’s common stock from April 1, 2026 through March 31, 2029. Under the program, the Company may purchase its shares from time to time in the open market, in privately negotiated transactions, or by other means in accordance with federal securities laws.
 
    
 
    
  “This share repurchase authorization demonstrates the Board and management team’s strong belief in our strategy and the path ahead to deliver compelling shareholder value. Built on the strength of our operations, and with the recent creation of our intellectual property joint venture with WHP Global, Lands’ End is well positioned to deliver for our shareholders and other stakeholders,” said Bernard McCracken, Chief Financial Officer. “By using the proceeds from our transaction with WHP Global to repay our term loan debt in full, we materially reduced our interest expense and significantly improved our balance sheet. From that balance sheet strength, and with this authorization in place, we have greater optionality and flexibility to evaluate and execute on opportunities to enhance shareholder value, including returning capital to shareholders.”
 
    
 
    
  The Company expects that purchases will be funded through existing cash on hand, cash from operations, distributions from the joint venture, borrowings under its asset-based senior secured credit facility or a combination of the foregoing. The amount and timing of the purchases will depend on a number of factors including the price and availability of the Company’s shares, trading volume and general market conditions. Repurchases may also be made under a Rule 10b5-1 plan, which would permit shares to be repurchased when the Company might otherwise be precluded from doing so under insider trading laws. The share repurchase program may be suspended or discontinued at any time.
 
    
 
    
  Under the Company’s prior share repurchase program, which expired on March 31, 2026, 1.26 million shares were repurchased for an aggregate $16.0 million beginning in April 2024. The aggregate dollar amount of stock could be repurchased by the Company per fiscal year under the prior program was limited by the provisions of the term loan, which are no longer applicable.
 
    
 
    
  
   About Lands' End, Inc.
  
 
    
 
    
  Lands’ End, Inc. (NASDAQ:LE) is a leading digital retailer of solution-based apparel, swimwear, outerwear, accessories, footwear, home products and uniforms. Lands’ End offers products online at
  
   www.landsend.com
  
  , through third-party distribution channels, our own Company Operated stores and third-party license agreements. Lands’ End also offers products to businesses and schools, for their employees and students, through the Outfitters distribution channel. Lands’ End is a classic American lifestyle brand that creates solutions for life’s every journey.
 
    
 
    
  
   Forward-Looking Statements
  
 
    
 
    
  This press release contains forward-looking statements that involve risks and uncertainties, including statements regarding the transactions by and among the Company, Lands’ End Direct Merchants, Inc., a wholly owned subsidiary of the Company (together with the Company, “Sellers”), WH Borrower, LLC, WHP Topco, L.P. (“WHP Topco”) and LEWHP LLC, a wholly owned indirect subsidiary of WHP Topco (the “Transactions”) and the related joint venture (“JV”), as well as statements regarding the Company’s plans relating to the Board’s share repurchase authorization and its anticipated impact, the Board and management team’s belief in Company strategy, the path ahead and ability to deliver compelling shareholder value; the Company’s positioning for the future; the impact of repayment of term loan debt, including reduced interest expense and improved balance sheet; and the Company’s ability to evaluate and execute on opportunities to enhance shareholder value and return capital to shareholders. The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in these forward-looking statements: the Company’s results may be materially impacted if tariffs on imports to the United States increase and it is unable to offset the increased costs from current or future tariffs through pricing negotiations with its vendor base, moving production out of countries impacted by the tariffs, passing through a portion of the cost increases to the customer, or other savings opportunities; global supply chain challenges and their impact on inbound transportation costs and delays in receiving product; disruption in the Company’s supply chain, including with respect to its distribution centers, third-party manufacturing partners and logistics partners, caused by limits in freight capacity, increases in transportation costs, port congestion, other logistics constraints, and closure of certain manufacturing facilities and production lines due to public health crises and other global economic conditions; the impact of global economic conditions, including inflation, on consumer discretionary spending; the impact of public health crises on operations, customer demand and the Company’s supply chain, as well as its consolidated results of operation, financial position and cash flows; the Company’s ability to offer merchandise and services that customers want to purchase; changes in customer preference from the Company’s branded merchandise; customers’ use of the Company’s digital platform, including customer acceptance of its efforts to enhance its eCommerce websites, including the Outfitters website; customer response to the Company’s marketing efforts across all types of media; the Company’s maintenance of a robust customer list; the Company’s retail store strategy may be unsuccessful; the Company’s Third Party channel may not develop as planned or have its desired impact; the Company’s dependence on information technology; failure of information technology systems, including with respect to its eCommerce operations, or an inability to upgrade or adapt its systems; failure to adequately protect against cybersecurity threats or maintain the security and privacy of customer, employee or company information and the impact of cybersecurity events on the Company; fluctuations and increases in costs of raw materials as well as fluctuations in other production and distribution-related costs; impairment of the Company’s relationships with its vendors; the Company’s failure to compete effectively in the apparel industry; legal, regulatory, economic and political risks associated with international trade and those markets in which the Company conducts business and sources its merchandise; the Company’s failure to protect or preserve the image of its brands and its intellectual property rights; increases in postage, paper and printing costs; failure by third parties who provide the Company with services in connection with certain aspects of its business to perform their obligations; the Company’s failure to timely and effectively obtain shipments of products from its vendors and deliver merchandise to its customers; reliance on promotions and markdowns to encourage customer purchases; the Company’s failure to efficiently manage inventory levels; unseasonal or severe weather conditions; natural disasters, political crises or other catastrophic events; the adverse effect on the Company’s reputation if its independent vendors or licensees do not use ethical business practices or comply with contractual obligations, applicable laws and regulations; assessments for additional state taxes; incurrence of charges due to impairment of other intangible assets and long-lived assets; the impact on the Company’s business of adverse worldwide economic and market conditions, including inflation and other economic factors that negatively impact consumer spending on discretionary items; the stock repurchase program may not be executed to the full extent within its duration, due to business or market conditions or Company credit facility limitations; the ability of the Company’s principal stockholders to exert substantial influence over the Company; uncertainty of the expected financial performance of the JV; the effects that a termination of the agreements governing the Transactions may have on the Company, including the possibility that there could be fluctuations in the trading price of the Company’s common stock as a result of the consummation of the Transactions; risks related to the Company’s ability to realize the anticipated benefits of the Transactions, including the possibility that the expected benefits from the Transactions will not be realized or will not be realized within the expected time period; the ability of the JV to implement its business strategy; the effects of the Transactions on relationships with employees, other business partners or governmental entities; negative effects of this announcement, the consummation of the Transactions on the market price of the Company’s common stock and/or the Company’s operating results, including current or future business; risks associated with potential significant volatility and fluctuations in the market price of the Company’s common stock; significant transaction costs; risks relating to the occurrence of an IPO, change of control or significant asset sale of WHP Topco (an “exchange event”), which is out of the Company and its stockholders’ control, to realize value from the Company’s exchange rights, and the possibility that such exchange event may never occur, or if it does occur, the possibility that it occurs on unfavorable terms, including economic terms; the possibility that one or more of the agreements governing the Transactions may contain provisions that are difficult to enforce and the possibility of legal disputes between Sellers and WHP Topco and its affiliates that could delay realization of the full benefits of the Transactions; the possibility that any exchange event could be structured in a manner and on terms and conditions that are disadvantageous to the Company and its stockholders; the possibility that the contribution of the Company’s intellectual property into the JV may not achieve the anticipated results, particularly if such intellectual property is not monetized effectively; the risk that WHP Global’s past performance may not be representative of future results; uncertainties relating to the JV’s ability to maintain the Company’s brand name and image with customers; uncertainties relating to the JV’s ability to respond to changing consumer preferences, identify and interpret consumer trends, and successfully market new products; uncertainties regarding the Company’s and the JV’s focus, strategic plans and other management actions; the risk that stockholder litigation in connection with the Transactions or other litigation, settlements or investigations may affect the timing or occurrence of the Transactions or result in significant costs of defense, indemnification and liability; the occurrence of any event that could give rise to termination of the Transactions; risks related to the disruption of management time from ongoing business operations due to the pendency of the Transactions, or other effects of the pendency of the Transactions on the relationship of any of the parties to the transaction with their employees, customers, suppliers, or other counterparties; global economic, political, legislative, regulatory and market conditions (including competitive pressures), evolving legal, regulatory and tax regimes, including the effects of tariffs, inflation and foreign currency exchange rate fluctuations around the world, the challenging consumer retail market in the United States and around the world and the impact of war and other conflicts around the world; and other risks, uncertainties and factors discussed in the “Risk Factors” sections of the Company’s Annual Report on Form 10-K for the fiscal year ended January 30, 2026. The Company intends the forward-looking statements to speak only as of the time made and does not undertake to update or revise them as more information becomes available, except as required by law.
  
    
 
    
 
    
  
   CONTACTS:
  
 
    
 
    
  Lands’ End, Inc.
  
    
  Bernard McCracken
  
    
  Chief Financial Officer
  
    
  (608) 935-4100
 
    
 
    
  Investor Relations:
  
    
  ICR, Inc.
  
    
  Tom Filandro
  
    
  (646) 277-1235
  
    
  
   [email protected]
  
 
    
 
    

    

    
                
    
              
    
            
    
          
    
          
          
    
            
              
            
          
    
          
          
            
          
            Read Full Article
        
    
      
    
    
      
    
        
    
          
    
            Edible Garden Recognized in 2025 FoodTech 500 Ranking for Innovation in Sustainable Agriculture
            
    
              an hour ago | April 1, 2026 1:22 p.m. UTC
              
    
                
    
                  
    Edible Garden recognized in the 2025 FoodTech 500 for innovation in sustainable agriculture and food technology.
    Quiver AI Summary
    Edible Garden AG Incorporated has been recognized in the 2025 FoodTech 500 list published by Forward Fooding, marking the company's fourth consecutive year on this prestigious ranking that highlights innovative firms at the intersection of food, technology, and sustainability. Selected from over 1,200 candidates across 87 countries, Edible Garden is acknowledged for its achievements in controlled environment agriculture and its commitment to sustainable practices. CEO Jim Kras emphasized the company’s focus on developing efficient, waste-reducing solutions while addressing the growing demand for locally produced, sustainable food. Edible Garden utilizes advanced farming techniques and proprietary technologies to enhance product quality and sustainability, further establishing its presence in the AgriFoodTech ecosystem with a diverse portfolio of organic produce and nutrition products available in thousands of retail locations.
    Potential Positives
    • Edible Garden has been recognized in the prestigious FoodTech 500 for the fourth consecutive year, highlighting its consistent innovation and leadership in sustainable agriculture.
    • The company was selected from over 1,200 applicants across 87 countries, emphasizing its global recognition and competitive position in the AgriFoodTech sector.
    • Edible Garden's growth in sustainable practices aligns with increasing consumer demand for locally produced, organic food, positioning the company well for future market opportunities.
    • The announcement reflects Edible Garden's integrated approach combining technology and sustainability, including patented systems that enhance operational efficiency and reduce waste.
    Potential Negatives
    • While being named to the FoodTech 500 indicates recognition and innovation, the press release does not provide specific data on financial performance or growth metrics, which may raise concerns about the company's actual market position and viability.
    • The focus on awards and methodologies without detailing concrete competitive advantages or market challenges may suggest a lack of substantive operational achievements.
    • The expansion of their facility into a dedicated nutrition manufacturing hub suggests a pivot towards higher-margin products, which could indicate previous struggles with profitability in their core areas.
    FAQ
    What is the FoodTech 500 ranking?
    The FoodTech 500 is a global ranking that recognizes innovative companies at the intersection of food, technology, and sustainability.
    How many companies were considered for the 2025 FoodTech 500?
    More than 1,200 applicants from 87 countries were evaluated for the 2025 FoodTech 500 ranking.
    What does Edible Garden focus on?
    Edible Garden focuses on controlled environment agriculture, delivering locally grown, organic, and sustainable produce and products.
    What is Edible Garden's Farm to Formula® approach?
    The Farm to Formula® approach integrates cultivation with value-added products, enhancing sustainability and reducing waste in the food supply chain.
    How does Edible Garden enhance product efficiency?
    Edible Garden uses patented technologies, including GreenThumb software and self-watering displays, to improve operational efficiency and extend product shelf life.
    Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

    $EDBL Insider Trading Activity
    EDBL Insider Trades
    $EDBL insiders have traded $EDBL stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
    Here’s a breakdown of recent trading of $EDBL stock by insiders over the last 6 months:
    • JAMES E. KRAS  (President and CEO)  purchased 3,700 shares for an estimated $2,050
    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
    $EDBL Hedge Fund Activity
    We have seen 8 institutional investors add shares of $EDBL stock to their portfolio, and 3 decrease their positions in their most recent quarter.
    Here are some of the largest recent moves:
    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
    Full Release
    
 
    
  
    
 
    
 
    
  Edible Garden named to the 2025 FoodTech 500
 
    
 
    
  
   BELVIDERE, NJ, April  01, 2026  (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW),
  
  a leader in controlled environment agriculture (CEA), locally grown, organic and sustainable produce and products, today announced that it has been named to the 2025 FoodTech 500 by Forward Fooding, a leading AgriFoodTech organization.
 
    
 
    
  The FoodTech 500 is a prestigious global ranking recognizing the most innovative companies operating at the intersection of food, technology, and sustainability. The 2025 cohort was selected from more than 1,200 applicants across 87 countries, reflecting the continued global expansion and importance of sustainable food system innovation. The ranking is based on a proprietary methodology that evaluates companies across three key pillars: business size, digital footprint, and sustainability impact.
 
    
 
    
  “We are honored to be recognized in the FoodTech 500 for the fourth consecutive year, a reflection of the momentum we are building as we continue to expand our footprint in sustainable agriculture and food technology,” said Jim Kras, Chief Executive Officer of Edible Garden. “Our team remains focused on advancing innovative solutions that enhance efficiency, reduce waste, and improve product quality across the supply chain. As demand grows for locally produced, sustainably grown food, we are well positioned to meet that need while driving meaningful impact for retailers, consumers, and the environment.”
 
    
 
    
  “At Edible Garden, our differentiated Farm to Formula® approach builds on our deep roots in AgTech and controlled environment agriculture, enabling us to extend our capabilities beyond cultivation into value-added products and solutions. By leveraging advanced greenhouse growing techniques, our patented GreenThumb software, and our self-watering display technology, we are able to reduce waste, extend product shelf life, and drive operational efficiency across the supply chain. This integrated approach allows us to maximize the value of what we grow while supporting a more sustainable and resilient food ecosystem,” concluded Kras.
 
    
 
    
  
   ABOUT THE FOODTECH 500
  
 
    
 
    
  Inspired by the Fortune 500, the FoodTech 500 drafts the definitive list of the most groundbreaking global businesses at the intersection of food, technology & sustainability. The FoodTech 500’s mission is to shine a spotlight on the leading global innovators across the AgriFoodTech ecosystem, from farm to fork. These entrepreneurs and the companies they have founded are creating impactful solutions to better the global food system.
 
    
 
    
  
   ABOUT EDIBLE GARDEN
   
    ®
   
  
 
    
 
    
  Edible Garden AG Incorporated is a leader in controlled environment agriculture (CEA), delivering locally grown, organic, better-for-you, sustainable produce and products through its Zero-Waste Inspired
  
   ®
  
  next-generation farming model. Available in over 6,000 retail locations across the United States, Caribbean, and South America, Edible Garden is at the forefront of the CEA and sustainability technology movement, distinguished by its advanced safety-in-farming protocols, sustainable packaging, patented GreenThumb software, and innovative Self-Watering in-store displays. The Company operates state-of-the-art, vertically integrated greenhouses and processing facilities, including Edible Garden Heartland in Grand Rapids, Michigan; Edible Garden Prairie Hills in Webster City, Iowa; and its headquarters at Edible Garden Belvidere in New Jersey. It also partners with a network of contract growers strategically located near major U.S. markets to ensure freshness and reduce environmental impact. The Company is also expanding its Prairie Hills facility in Webster City, Iowa, into a dedicated ready-to-drink (RTD) clean nutrition manufacturing hub, supporting its Farm-to-Formula® strategy and its expansion into higher-margin, shelf-stable nutrition categories.
 
    
 
    
  Edible Garden’s proprietary GreenThumb 2.0 software—protected by U.S. Patents US 11,158,006 B1, US 11,410,249 B2, and US 11,830,088 B2—optimizes vertical and traditional greenhouse growing conditions while aiming to reduce food miles. Its patented Self-Watering display (U.S. Patent No. D1,010,365) is designed to extend plant shelf life and elevate in-store presentation. In addition to its core CEA operations, Edible Garden owns three patents in advanced aquaculture technologies: a closed-loop shrimp farming system (US 6,615,767 B1), a modular recirculating aquaculture setup with automated water treatment and feeding (US 10,163,199 B2), and a sensor-driven ammonia control method utilizing electrolytic chlorine generation (US 11,297,809 B1).
 
    
 
    
  The Company has been recognized as a FoodTech 500 firm by Forward Fooding, is a multi-year participant in Walmart’s Project Gigaton and a Giga Guru designee and has received NRG’s Excellence in Energy Award for its commitment to measurable environmental performance and energy stewardship. Edible Garden also develops and markets a growing line of nutrition and specialty food products, including Vitamin Way
  
   ®
  
  and Vitamin Whey
  
   ®
  
  —plant and whey protein powders—and Kick. Sports Nutrition, a premium performance line for health-conscious athletes seeking cleaner, better-for-you options. The Company’s offerings further include fresh, sustainable condiments such as Pulp fermented gourmet and chili-based sauces, as well as Pickle Party, a collection of fermented fresh pickles and krauts.
 
    
 
    
  Learn more at
  
   https://ediblegardenag.com
  
  
    
  
    
  For Pulp products, visit
  
   https://www.pulpflavors.com
  
  .
  
    
  For Vitamin Whey® products, visit
  
   https://vitaminwhey.com
  
  .
  
    
  For Kick. Sports Nutrition products, visit
  
   https://kicksportsnutrition.net/
  
  
    
 
    
 
    
  Watch the Company’s latest corporate video
  
   here
  
  .
 
    
 
    
  
   Investor Contacts:
  
  
    
  Crescendo Communications, LLC
  
    
  212-671-1020
  
    
  [email protected]
 
    
 
    
  
    
 
    
 
    
  
    
 
    
 
    
  
   Attachment
  
 
    
 
 
    

    

    
                
    
              
    
            
    
          
    
          
          
    
            
              
            
          
    
          
          
            
          
            Read Full Article
        
    
      
    
    
      
    
        
    
          
    
            Seanergy Maritime Holdings Corp. Files Annual Report on Form 20-F for Fiscal Year 2025
            
    
              an hour ago | April 1, 2026 1:22 p.m. UTC
              
    
                
    
                  
    Seanergy Maritime Holdings Corp. filed its Annual Report for 2025 with the SEC, accessible on its website.
    Quiver AI Summary
    Seanergy Maritime Holdings Corp. announced the filing of its Annual Report on Form 20-F for the fiscal year ending December 31, 2025, with the U.S. Securities and Exchange Commission. The report is accessible on the Company's website under the Investor Relations section. Seanergy, based in Glyfada, Greece, is a publicly traded pure-play Capesize ship-owner, operating a modern fleet of 20 vessels, with plans to expand to 23 vessels upon completing certain transactions. The Company emphasizes that its forward-looking statements are subject to risks and uncertainties that could cause actual results to differ from expectations, including market conditions, financial performance, and geopolitical issues. For more information, interested parties can contact Seanergy's Investor Relations or Capital Link.
    Potential Positives
    • The filing of the Annual Report on Form 20-F demonstrates compliance with U.S. Securities and Exchange Commission regulations, enhancing the company's credibility and transparency with investors.
    • Seanergy's projected fleet expansion from 20 to 23 vessels, along with an increase in cargo carrying capacity, indicates growth and potential for higher revenues.
    • The company positions itself as a prominent player in the Capesize sector of the maritime industry, which could attract more investor interest and bolster its stock performance.
    Potential Negatives
    • The average age of the fleet is approximately 14.7 years, which may indicate potential maintenance and operational challenges compared to newer vessels in the industry.
    • The press release emphasizes significant uncertainties and risks associated with the company's financial performance and operational results, which could deter potential investors.
    • There is a lack of specific details regarding the performance and financial health of the company for the fiscal year 2025, which may raise concerns among stakeholders about the transparency and clarity of the company's situation.
    FAQ
    What is Seanergy Maritime Holdings Corp.?
    Seanergy Maritime Holdings Corp. is a pure-play Capesize ship-owner providing marine dry bulk transportation services.
    When was the Annual Report filed?
    The Annual Report on Form 20-F was filed with the SEC on April 1, 2026.
    How can I access Seanergy's Annual Report?
    The Annual Report can be accessed on Seanergy’s website under the “Investor Relations” section.
    What is the average age of Seanergy's fleet?
    The average age of Seanergy's fleet is approximately 14.7 years.
    What stock exchange does Seanergy trade on?
    Seanergy's common shares trade on the Nasdaq Capital Market under the symbol “SHIP”.
    Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

    $SHIP Hedge Fund Activity
    We have seen 26 institutional investors add shares of $SHIP stock to their portfolio, and 26 decrease their positions in their most recent quarter.
    Here are some of the largest recent moves:
    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
    Full Release
    
 
    
  GLYFADA, Greece, April  01, 2026  (GLOBE NEWSWIRE) -- Seanergy Maritime Holdings Corp. (the “Company” or “Seanergy”) (NASDAQ: SHIP) announced today that its Annual Report on Form 20-F for the fiscal year ended December 31, 2025 (the “Annual Report”) has been filed with U.S. Securities and Exchange Commission. The Annual Report may also be accessed through Seanergy’s website,
  
   www.seanergymaritime.com
  
  , at the “Investor Relations” section under “Financial Reports”.
 
    
 
    
  
   About Seanergy Maritime Holdings Corp.
  
 
    
 
    
  Seanergy Maritime Holdings Corp. is a prominent pure-play Capesize ship-owner publicly listed in the U.S. Seanergy provides marine dry bulk transportation services through a modern fleet of Capesize vessels. The Company owns or finance leases 20 vessels (2 Newcastlemax and 18 Capesize) with an average age of approximately 14.7 years and an aggregate cargo carrying capacity of approximately 3,633,861 dwt. Upon completion of the sales of the M/Vs Squireship, Dukeship, and the delivery of the newbuilding vessels, the Company is expected to own or finance lease 23 vessels (3 Newcastlemax and 20 Capesize), with an aggregate cargo carrying capacity of approximately 4,218,890 dwt.
 
    
 
    
  The Company is incorporated in the Republic of the Marshall Islands and has executive offices in Glyfada, Greece. The Company's common shares trade on the Nasdaq Capital Market under the symbol “SHIP”.
 
    
 
    
  Please visit our company website at:
  
   www.seanergymaritime.com
  
  .
 
    
 
    
  
   Forward-Looking Statements
  
 
    
 
    
  This press release contains forward-looking statements (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) concerning future events, including with respect to declaration of dividends, market trends and shareholder returns. Words such as “may”, “should”, “expects”, “intends”, “plans”, “believes”, “anticipates”, “hopes”, “estimates” and variations of such words and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks and are based upon a number of assumptions and estimates, which are inherently subject to significant uncertainties and contingencies, many of which are beyond the control of the Company. Actual results differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, the Company’s operating or financial results; the Company’s liquidity, including its ability to service its indebtedness; competitive factors in the market in which the Company operates; shipping industry trends, including charter rates, vessel values and factors affecting vessel supply and demand; future, pending or recent acquisitions and dispositions, business strategy, impacts of litigation, areas of possible expansion or contraction, and expected capital spending or operating expenses; risks associated with operations outside the United States; risks arising from trade disputes between the U.S. and China, including the re-imposition of reciprocal port fees; broader market impacts arising from trade disputes or war (or threatened war) or international hostilities, such as between the U.S. and Venezuela, Israel and Hamas or Iran, China and Taiwan and Russia and Ukraine; risks associated with the length and severity of pandemics; and other factors listed from time to time in the Company’s filings with the SEC, including its most recent annual report on Form 20-F. The Company’s filings can be obtained free of charge on the SEC’s website at www.sec.gov. Except to the extent required by law, the Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.
 
    
 
    
  
   For further information please contact
  
  :
 
    
 
    
  Seanergy Investor Relations
  
    
  Tel: +30 213 0181 522
  
    
  E-mail:
  
   [email protected]
  
 
    
 
    
  Capital Link, Inc.
  
    
  Paul Lampoutis
  
    
  230 Park Avenue Suite 1540
  
    
  New York, NY 10169
  
    
  Tel: (212) 661-7566
  
    
  E-mail:
  
   [email protected]
  
 
    
 
    

    

    
                
    
              
    
            
    
          
    
          
          
    
            
              
            
          
    
          
          
            
          
            Read Full Article
        
    
      
    
    
      
    
        
    
          
    
            Algorhythm Holdings, Inc. to Announce Full Year 2025 Financial Results on April 2, 2026
            
    
              an hour ago | April 1, 2026 1:22 p.m. UTC
              
    
                
    
                  
    Algorhythm Holdings will release its full-year 2025 financial results on April 2, 2026, with a conference call to follow.
    Quiver AI Summary
    Algorhythm Holdings, Inc. announced that it will release its financial results for the full year 2025 on April 2, 2026, and will hold a conference call at 10:00 a.m. Eastern Time the same day to discuss these results and provide a business update. The call can be accessed via a dial-in number, and an audio rebroadcast will be available later on their website. Algorhythm Holdings focuses on AI technology, particularly through its subsidiary SemiCab, which offers a cloud-based platform for optimizing logistics and supply chain solutions. The platform helps retailers and transportation providers streamline operations and enhance efficiency. The press release also includes forward-looking statements subject to risks and uncertainties, and a reminder about the importance of consulting SEC reports for more information.
    Potential Positives
    • The announcement of the upcoming financial results for the full year 2025 demonstrates the company's commitment to transparency and provides stakeholders with critical information regarding its financial health.
    • Hosting a conference call for investors signals active engagement with shareholders and the investment community, which can enhance investor relations and potentially increase investor confidence.
    • SemiCab's advancement as a leading AI technology solution in logistics reflects the company's innovative capabilities and could position it favorably in the growing logistics and supply chain market.
    • The use of AI and real-time data integration within SemiCab's platform highlights the company's technological strength and potential for operational efficiency, which may attract more clients and partnerships.
    Potential Negatives
    •  The press release does not provide any specific details about the financial results and performance metrics, which could raise concerns among investors about the company's transparency and ability to meet expectations.
    •  The inclusion of forward-looking statements coupled with cautionary language may imply that there are significant uncertainties or risks regarding the company's future performance that investors should be wary of.
    •  No positive financial metrics or achievements were highlighted in the press release, potentially leading to investor apprehension about the company's current standing and growth trajectory.
    FAQ
    When will Algorhythm Holdings announce its financial results for 2025?
    Algorhythm Holdings will announce its financial results on April 2, 2026.
    What time is the conference call for financial results?
    The conference call is scheduled for 10:00 a.m. Eastern Time on April 2, 2026.
    How can I join the Algorhythm Holdings conference call?
    You can join by calling 888-999-3182 and using the Conference ID: RIME.
    Where can I find a rebroadcast of the conference call?
    An audio rebroadcast will be available later on the same day at https://algoholdings.com/investors.
    What is SemiCab, and how does it relate to Algorhythm Holdings?
    SemiCab is a cloud-based AI platform by Algorhythm enabling optimization in logistics and addressing supply chain challenges.
    Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

    $RIME Hedge Fund Activity
    We have seen 4 institutional investors add shares of $RIME stock to their portfolio, and 4 decrease their positions in their most recent quarter.
    Here are some of the largest recent moves:
    • HRT FINANCIAL LP removed 13,777 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $13,914
    • VIRTU FINANCIAL LLC added 11,281 shares (+inf%) to their portfolio in Q4 2025, for an estimated $11,393
    • VANGUARD GROUP INC removed 4,782 shares (-23.9%) from their portfolio in Q4 2025, for an estimated $4,829
    • TOWER RESEARCH CAPITAL LLC (TRC) added 1,981 shares (+110.6%) to their portfolio in Q4 2025, for an estimated $2,000
    • OSAIC HOLDINGS, INC. removed 650 shares (-13.0%) from their portfolio in Q4 2025, for an estimated $656
    • UBS GROUP AG added 462 shares (+1650.0%) to their portfolio in Q4 2025, for an estimated $466
    • GEODE CAPITAL MANAGEMENT, LLC removed 280 shares (-1.4%) from their portfolio in Q4 2025, for an estimated $282
    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
    Full Release
    
 
    
  
   Fort Lauderdale, FL, April  01, 2026  (GLOBE NEWSWIRE) --
  
  Algorhythm Holdings, Inc. (NASDAQ: RIME), a leading AI technology company, today announced that it will release its financial results for the full year 2025 on Thursday, April 2, 2026. Management will host a conference call that same day on Thursday, April 2, 2026, at 10:00 a.m. Eastern Time to discuss the financial results and provide a business update.
 
    
 
    
  
   Conference Call Details:
  
 
    
 
    
  Date: Thursday, April 2, 2026
  
    
  Time: 10:00 a.m. EDT
  
    
  Dial-in number: 888-999-3182
  
    
  Conference ID: RIME
 
    
 
    
  An audio rebroadcast of the call will be available later in the day at:
 
    
 
    
  
   https://algoholdings.com/investors
  
 
    
 
    
  
   About Algorhythm Holdings
  
 
    
 
    
  Algorhythm Holdings, Inc. is a leading AI technology company focused on the growth and development of SemiCab, an emerging leader in the global logistics and distribution industry. Since 2020, SemiCab has enabled major retailers, brands and transportation providers to address common supply-chain problems globally. Its AI-enabled, cloud-based Collaborative Transportation Platform achieves the scalability required to predict and optimize millions of loads and hundreds of thousands of trucks. SemiCab uses real-time data from API-based load tendering and pre-built integrations with TMS and ELD partners to orchestrate collaboration across manufacturers, retailers, distributors, and their carriers. SemiCab uses AI/ML predictions and advanced predictive optimization models to enable fully loaded round trips. With SemiCab’s AI platform, shippers pay less and carriers make more without having to change a thing. For additional information, please go to:
  
   http://www.semicab.com
  
 
    
 
    
  
   Investor Relations Contact
  
 
    
 
    
  Brendan Hopkins
  
    
  407-645-5295
  
    
  
   [email protected]
  
  
    
  
   www.algoholdings.com
  
  
    
 
    
 
    
  
   Media Contact
  
 
    
 
    
  FischTank PR
  
    
  
   [email protected]
  
 
    
 
    
  
   Forward Looking Statements
  
 
    
 
    
  
   This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Any statement that is not historical in nature is a forward-looking statement and may be identified by the use of words and phrases such as "expects," "anticipates," "believes," "will," "will likely result," "will continue," "plans to," "potential," "promising," and similar expressions. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including the risk factors described from time to time in Algorhythm’s reports to the SEC, including, without limitation Algorhythm’s Annual Report on Form 10-K for the year ended December 31, 2025.
  
  
   You should not place undue reliance on any forward-looking statement, each of which applies only as of the date of this press release. Except as required by law, we undertake no obligation to update or revise publicly any of the forward-looking statements after the date of this press release to conform our statements to actual results or changed expectations, or as a result of new information, future events or otherwise.
  
 
    
 
    

    

    
                
    
              
    
            
    
          
    
          
          
    
            
              
            
          
    
          
          
            
          
            Read Full Article
        
    
      
    
    
      
    
        
    
          
    
            Merit Medical Systems, Inc. Acquires View Point Medical, Inc. for $140 Million to Enhance Oncology Product Offerings
            
    
              an hour ago | April 1, 2026 1:22 p.m. UTC
              
    
                
    
                  
    Merit Medical acquires View Point Medical for $140 million, enhancing its oncology product offerings.
    Quiver AI Summary
    Merit Medical Systems, Inc. has acquired View Point Medical, Inc. for approximately $140 million, making View Point a wholly-owned subsidiary. This acquisition enhances Merit's oncology product portfolio, particularly in breast cancer localization technologies, including View Point's OneMark® Detection Imaging System. The deal involves a $90 million cash payment at closing, with two deferred payments of $25 million each over the next two years. Merit anticipates the acquisition will contribute $2 to $4 million in revenue for the remainder of 2026 and potentially $14 to $16 million for the following year. Despite some projected dilutive effects on earnings in the short term, the acquisition aligns with Merit's mission to improve cancer care and is expected to leverage their existing SCOUT® localization technology effectively. Further details will be discussed in Merit's upcoming investor conference call on April 30, 2026.
    Potential Positives
    • Merit Medical Systems has acquired View Point Medical, enhancing its portfolio in therapeutic oncology products and providing innovative technologies for breast and soft tissue tumor localization.
    • The acquisition is projected to contribute $14 million to $16 million in revenue for the year ending December 31, 2027, indicating strong financial growth potential.
    • The integration of View Point's OneMark system with Merit’s existing SCOUT platform offers physicians more localization options during biopsy procedures, potentially streamlining treatment processes for breast cancer patients.
    • Merit maintains a market leadership position in wire-free, non-radioactive breast localization procedures, which may further solidify its competitive advantage in the oncology medical device market.
    Potential Negatives
    • The acquisition of View Point Medical includes a substantial financial commitment of approximately $140 million, which could strain Merit’s financial resources, especially if the expected revenue growth does not materialize.
    • The projected dilution to Merit’s GAAP net income and earnings per share in both 2026 and 2027 indicates potential challenges in achieving financial targets post-acquisition.
    • The limited 2026 revenue contribution projection of only $2 million to $4 million raises concerns regarding the immediate financial benefits of the acquisition and suggests uncertainty about successful integration and performance of the acquired business.
    FAQ
    What company did Merit Medical acquire?
    Merit Medical acquired View Point Medical, Inc., which is now a wholly-owned subsidiary.
    What is the purpose of the OneMark System?
    The OneMark System is designed for the accurate diagnosis and localization of breast and soft tissue tumors.
    How much did Merit pay for the View Point acquisition?
    The total consideration for the acquisition is approximately $140 million, including cash and deferred payments.
    When is Merit Medical's first quarter investor call scheduled?
    The investor call is scheduled for April 30, 2026, following the merger announcement.
    How will the acquisition impact Merit’s financials in 2027?
    The acquisition is projected to contribute revenue of $14 million to $16 million and be accretive to non-GAAP earnings per share.
    Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

    $MMSI Insider Trading Activity
    MMSI Insider Trades
    $MMSI insiders have traded $MMSI stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
    Here’s a breakdown of recent trading of $MMSI stock by insiders over the last 6 months:
    • FRED P. LAMPROPOULOS  (Executive Chairman) has made 0 purchases and 4 sales selling 60,000 shares for an estimated $5,189,907.
    • NEIL W. PETERSON  (CHIEF OPERATING OFFICER)  sold 5,000 shares for an estimated $450,000
    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
    $MMSI Revenue
    MMSI Quarterly Revenue
    $MMSI had revenues of $393.9M in Q4 2025. This is an increase of 10.92% from the same period in the prior year.
    You can track MMSI financials on Quiver Quantitative's MMSI stock page.
    $MMSI Hedge Fund Activity
    We have seen 220 institutional investors add shares of $MMSI stock to their portfolio, and 160 decrease their positions in their most recent quarter.
    Here are some of the largest recent moves:
    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
    $MMSI Analyst Ratings
    Wall Street analysts have issued reports on $MMSI in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
    Here are some recent analyst ratings:
    • Piper Sandler issued a "Overweight" rating on 02/18/2026
    • Needham issued a "Buy" rating on 01/09/2026
    • Wells Fargo issued a "Overweight" rating on 11/14/2025
    • Canaccord Genuity issued a "Buy" rating on 11/14/2025
    • Barrington Research issued a "Outperform" rating on 11/14/2025
    To track analyst ratings and price targets for $MMSI, check out Quiver Quantitative's $MMSI forecast page.
    $MMSI Price Targets
    Multiple analysts have issued price targets for $MMSI recently. We have seen 6 analysts offer price targets for $MMSI in the last 6 months, with a median target of $103.5.
    Here are some recent targets:
    • Larry Biegelsen from Wells Fargo set a target price of $78.0 on 02/26/2026
      •  
    • Mike Matson from Needham set a target price of $101.0 on 02/25/2026
      •  
    • Michael Petusky from Barrington Research set a target price of $109.0 on 02/25/2026
      •  
    • Jason Bednar from Piper Sandler set a target price of $106.0 on 02/18/2026
      •  
    • Sam Eiber from BTIG set a target price of $107.0 on 02/06/2026
      •  
    • Jon Young from Canaccord Genuity set a target price of $99.0 on 12/17/2025
      •  
    Full Release
    
 
    
  SOUTH JORDAN, Utah, April  01, 2026  (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has acquired View Point Medical, Inc. (View Point). Through a merger transaction, View Point is now a wholly-owned subsidiary of Merit. View Point, located in Carlsbad, California, manufactures the OneMark
  
   ®
  
  Detection Imaging System and OneMark Tissue Markers. The aggregate transaction consideration, including the assumption of ViewPoint liabilities, is approximately $140 million. Of that amount, $90 million was paid in cash at closing and two deferred payments of $25 million each are scheduled to be paid not later than the first and second anniversaries of the closing date, respectively.
 
    
 
    
  “This acquisition expands Merit’s portfolio of therapeutic oncology products dedicated to the accurate diagnosis and localization of breast and soft tissue tumors,” said Martha G. Aronson, Merit’s President and Chief Executive Officer. “Merit has built a market leadership position in wire-free, non-radioactive breast localization procedures. This leadership is built upon our SCOUT
  
   ®
  
  platform, which utilizes the precision and accuracy of radar. View Point’s unique ultrasound-enhanced technology offers a highly innovative solution to localize more lesions at the time of biopsy – representing an estimated 1.3 million procedures annually in the United States alone. We look forward to discussing this acquisition in further detail on our first quarter investor conference call.” Merit’s first quarter investor call is scheduled for April 30, 2026.
 
    
 
    
  The OneMark System is US Food and Drug Administration (FDA) cleared for its intended use and consists of a surgical detection console and ultrasound-enhanced tissue markers. After placement, the tissue markers are designed to be visible across commonly used imaging modalities and engineered to minimize interference with imaging studies. The combination of SCOUT and OneMark provides physicians with more localization options during the initial diagnostic biopsy, which may reduce the need for a separate procedure to mark the location of the tumor prior to surgery.
 
    
 
    
  “The acquisition of View Point reinforces Merit’s mission to help reduce the burden that breast cancer places on patients and their loved ones,” said Adam Smith, Merit’s Chief Commercial Officer. “As treatment protocols evolve, the suspicious area is often most visible at the time of biopsy. Localizing these areas early in a patient’s cancer journey can help physicians plan treatment and may help reduce the need for additional localization procedures.”
 
    
 
    
  
   FINANCIAL SUMMARY
  
 
    
 
    
  From the acquisition effective date of April 1, 2026 through December 31, 2026, the acquisition is projected to contribute revenue in the range of $2 million to $4 million and to dilute Merit’s previously forecasted non-GAAP earnings per share by approximately $0.05, inclusive of approximately $2.0 million of lower interest income on cash balances used for the total purchase consideration and excluding approximately $5.3 million of non-cash and non-recurring transaction-related expenses, and to be dilutive to Merit’s full-year 2026 GAAP net income and GAAP earnings per share.
 
    
 
    
  For the twelve months ending December 31, 2027, the acquisition is projected to contribute revenue in the range of $14 million to $16 million and to be accretive to non-GAAP earnings per share. Sales of View Point’s OneMark System are projected to grow at least 20% per year, with 70% non-GAAP gross margins and accretive to non-GAAP operating margins. The acquisition is projected to be dilutive to Merit’s GAAP net income and GAAP earnings per share in 2027 and accretive thereafter.
 
    
 
    
  
   NON-GAAP FINANCIAL MEASURES
  
 
    
 
    
  Merit generally does not provide guidance for GAAP reported financial measures (other than revenue) or a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP reported financial measures (other than revenue) because Merit is unable to predict with reasonable certainty the financial impact of various items which could impact Merit’s future financial results, such as expenses attributable to acquisitions or other extraordinary transactions, non-cash expenses related to amortization or write-off of previously acquired tangible and intangible assets, certain employee termination benefits, performance-based stock compensation expenses, expenses resulting from non-ordinary course litigation or administrative proceedings and resulting settlements, governmental proceedings, and changes in governmental or industry regulations. These items are uncertain, depend on various factors, and could have a material impact on GAAP reported results for the guidance period. For the same reasons, Merit is unable to address the significance of the unavailable information, which could be material to future results. Specifically, Merit is not, without unreasonable effort, able to reliably predict the impact of these items, and Merit believes inclusion of a reconciliation of these forward-looking non-GAAP measures to their GAAP counterparts could be confusing to investors or cause undue reliance. Only information on the impacts to such measures from the proposed acquisition is included in this release. A reconciliation of the impacts on such financial measures to the impacts on their GAAP counterparts is not available without unreasonable effort.
 
    
 
    
  
   ADVISORS
  
 
    
 
    
  Piper Sandler & Co. acted as financial advisor to Merit. Baker & McKenzie LLP served as legal advisor to Merit.
 
    
 
    
  
   ABOUT MERIT MEDICAL
  
  
    
  Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,600 people worldwide.
 
    
 
    
  
   CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
  
 
    
 
    
  This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others:
 
    
 
      
  
    • 
   Statements proceeded or followed by, or that include the words, “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “intends,” “seeks,” “believes,” “estimates,” “projects,” “forecasts,” “potential,” “target,” “continue,” “upcoming,” “optimistic” or other forms of these words or similar words or expressions, or the negative thereof or other comparable terminology;
  
      • 
  
    • 
   Statements that address Merit’s future operating performance or events or developments that Merit’s management expects or anticipates will occur, including, without limitation, any statements regarding Merit’s projected revenues, revenue growth or other financial measures, Merit’s plans and objectives for future operations, Merit’s proposed new products or services, the integration, development or commercialization of the business or any assets acquired from other parties, future economic conditions or performance, the implementation of, and results which may be achieved through, Merit’s Continued Growth Initiatives Program or other business optimization initiatives, and any statements of assumptions underlying any of the foregoing; and
  
      • 
  
    • 
   Statements regarding Merit’s past performance, efforts, or results about which inferences or assumptions may be made, including statements proceeded or followed by the words "preliminary," "initial," "potential," "possible," "diligence," "industry-leading," "compliant," "indications," or "early feedback" or other forms of these words or similar words or expressions, or the negative thereof or other comparable terminology.
  
      • 
 
    
 
    
  The forward-looking statements contained in this release are based on Merit management’s current expectations and assumptions regarding future events or outcomes. If underlying expectations or assumptions prove inaccurate, or risks or uncertainties materialize, actual results will likely differ, and could differ materially, from Merit’s expectations reflected in any forward-looking statements. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results. Investors are cautioned not to unduly rely on any such forward-looking statements.
 
    
 
    
  The following are some of the important risks and uncertainties that could cause Merit’s actual results to differ from Merit’s expectations in any forward-looking statements: risks and uncertainties associated with Merit’s acquisition of View Point and the OneMark Tissue Localization System and related technology; risks and uncertainties associated with Merit’s integration of the View Point business, assets and operations into its operations and its ability to achieve anticipated financial results, product development and other anticipated benefits of the acquisition; uncertainties as to whether Merit will achieve revenue or other financial performance consistent with its forecasts projected for the View Point acquisition; risks and uncertainties associated with Merit’s executive succession and leadership transition; risks and uncertainties regarding trade policies or related actions implemented by the United States or other countries, including existing, proposed, prospective or invalidated tariffs, duties or other measures; risks and uncertainties associated with Merit’s integration of businesses or assets acquired from third parties, including the business and assets related to the C2 CryoBalloon™ device acquired from Pentax of America, Inc. in November 2025, Biolife Delaware, L.L.C. in May 2025 and the businesses and assets acquired from Cook Medical Holdings LLC in November 2024 and EndoGastric Solutions, Inc. in July 2024, and Merit’s ability to achieve the anticipated operating and financial results, product development and other anticipated benefits of such acquisitions; effects of Merit’s 3.00% Convertible Senior Notes due 2029 on Merit’s net income and earnings per share performance; disruptions in Merit’s supply chain, manufacturing or sterilization processes; U.S. and global political, economic, competitive, reimbursement and regulatory conditions; modification or limitation of, or policies and procedures associated with, governmental or private insurance reimbursement policies; reduced availability of, and price increases associated with, components and other raw materials; increases in transportation expenses; risks relating to Merit’s potential inability to successfully manage growth through acquisitions generally, including the inability to effectively integrate acquired operations or products or commercialize technology developed internally or acquired through completed, proposed or future transactions; prospective financial obligations or other uncertainties associated with Merit’s divestiture of its DualCap
  
   ®
  
  anti-microbial cap product line in February 2026; fluctuations in interest or foreign currency exchange rates and inflation; cybersecurity events; government scrutiny and regulation of the medical device industry; difficulties relating to development, testing and regulatory approval, clearance and maintenance of Merit’s products; the safety, efficacy and patient and physician adoption of Merit’s products; the ability to fully enroll and the outcomes of ongoing and future clinical trials and market studies relating to Merit’s products; litigation and other legal proceedings affecting Merit; the risk and possible effects of any failure to comply with U.S. and foreign laws and regulations; restrictions on Merit’s liquidity or business operations resulting from its debt agreements; infringement of Merit’s technology or the assertion that Merit’s technology infringes the rights of other parties; product recalls and product liability claims; potential for significant adverse changes in governing regulations;, changes in tax laws and regulations in the United States or other jurisdictions or exposure to additional tax liabilities which may adversely affect Merit’s effective tax rate; termination of relationships with Merit’s suppliers, or failure of such suppliers to perform; development of new products and technology that could render Merit’s existing or future products obsolete; market acceptance of new products; failure to comply with applicable environmental laws; changes in key personnel; labor shortages and increases in labor costs; price and product competition; extreme weather events; and geopolitical events. For a further discussion of the risks and uncertainties that may affect Merit’s business, operations and financial condition, see Part I, Item 1A. “Risk Factors” in Merit’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC.
 
    
 
    
  All subsequent forward-looking statements attributable to Merit or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results. Those estimates and all other forward-looking statements included in this release are made only as of the date of this release, and except as otherwise required by applicable law, Merit assumes no obligation to update or disclose revisions to estimates and all other forward-looking statements.
 
    
 
    
  
   TRADEMARKS
  
 
    
 
    
  Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc., its subsidiaries, or its licensors.
 
    
 
    
  
   CONTACTS
  
  
    
  
    
  PR/Media Inquiries
  
    
  Sarah Comstock
 
    
 
    
  Merit Medical Systems, Inc.
  
    
  +1-801-432-2864 |
  
   [email protected]
  
 
    
 
    
  Investor Inquiries
  
    
  Mike Piccinino, CFA, IRC
  
    
  ICR Healthcare
  
    
  +1-443-213-0509 |
  
   [email protected]
  
 
    
 
    

    

    
                
    
              
    
            
    
          
    
          
          
    
            
              
            
          
    
          
          
            
          
            Read Full Article
        
    
      
    
    
      
    
        
    
          
    
            Congress Trade: Representative Mark Alford Just Disclosed New Stock Trades
            
    
              an hour ago | April 1, 2026 1:12 p.m. UTC
              
    
                
    
                  
    Representative Mark Alford just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Mark Alford and other politicians.
    The trades in the new disclosure included a:
    • Sale of $AMZN stock (AMAZON.COM, INC. - COMMON STOCK)
    • Sale of $SPYB stock (SOLD @ $493.42/SHARE SPY – 8.318 SHARES SOLD @ $670.024/SHARE DIA – 8.426 SHARES SOLD @ $470.985/SHARE SPYD – 57.383 SHARES SOLD @ $46.04/SHARE AMZN – 25 SHARES SOLD @ $209.40/SHARE AAPL – 20.313 SHARES SOLD @ $253.45/SHARE QQQ – 4.105 SHARES SOLD @ $601.68/SHARE PYPL – 9.021 SHARES SOLD @ $47.735/SHARE SPDR S&P 500 BUYBACK ETF)
    • Sale of $BRK.B stock (SOLD @ $493.42/SHARE SPY – 8.318 SHARES SOLD @ $670.024/SHARE DIA – 8.426 SHARES SOLD @ $470.985/SHARE SPYD – 57.383 SHARES SOLD @ $46.04/SHARE AMZN – 25 SHARES SOLD @ $209.40/SHARE AAPL – 20.313 SHARES SOLD @ $253.45/SHARE QQQ – 4.105 SHARES SOLD @ $601.68/SHARE PYPL – 9.021 SHARES SOLD @ $47.735/SHARE BERKSHIRE HATHAWAY INC. NEW COMMON STOCK)
    • Sale of $T stock (SOLD @ $493.42/SHARE SPY – 8.318 SHARES SOLD @ $670.024/SHARE DIA – 8.426 SHARES SOLD @ $470.985/SHARE SPYD – 57.383 SHARES SOLD @ $46.04/SHARE AMZN – 25 SHARES SOLD @ $209.40/SHARE AAPL – 20.313 SHARES SOLD @ $253.45/SHARE QQQ – 4.105 SHARES SOLD @ $601.68/SHARE PYPL – 9.021 SHARES SOLD @ $47.735/SHARE AT&T INC.)
    • Sale of $AAPL stock (SOLD @ $493.42/SHARE SPY – 8.318 SHARES SOLD @ $670.024/SHARE DIA – 8.426 SHARES SOLD @ $470.985/SHARE SPYD – 57.383 SHARES SOLD @ $46.04/SHARE AMZN – 25 SHARES SOLD @ $209.40/SHARE AAPL – 20.313 SHARES SOLD @ $253.45/SHARE QQQ – 4.105 SHARES SOLD @ $601.68/SHARE PYPL – 9.021 SHARES SOLD @ $47.735/SHARE APPLE INC. - COMMON STOCK)
    • Sale of $PYPL stock (SOLD @ $493.42/SHARE SPY – 8.318 SHARES SOLD @ $670.024/SHARE DIA – 8.426 SHARES SOLD @ $470.985/SHARE SPYD – 57.383 SHARES SOLD @ $46.04/SHARE AMZN – 25 SHARES SOLD @ $209.40/SHARE AAPL – 20.313 SHARES SOLD @ $253.45/SHARE QQQ – 4.105 SHARES SOLD @ $601.68/SHARE PYPL – 9.021 SHARES SOLD @ $47.735/SHARE PAYPAL HOLDINGS, INC. - COMMON STOCK)
    To see all the trades, and to see details on the trade sizes and dates, see Quiver Quantitative's politician page for Representative Mark Alford
    
                
    
              
    
            
    
          
    
          
          
    
            
              
            
          
    
          
          
            
          
            Read Full Article
        
    
      
    
    
      
    
        
    
          
    
            LAMB WESTON HOLDINGS ($LW) Releases Q3 2026 Earnings
            
    
              2 hours ago | April 1, 2026 12:55 p.m. UTC
              
    
                
    
                  
    LAMB WESTON HOLDINGS ($LW) posted quarterly earnings results for Q3 2026 on Wednesday, April 1st. The company reported earnings of $0.72 per share, beating estimates of $0.64 by $0.08. The company also reported revenue of $1,564,800,000, beating estimates of $1,538,803,520 by $25,996,480.
    You can see Quiver Quantitative's $LW stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
    LAMB WESTON HOLDINGS Insider Trading Activity
    LW Insider Trades
    LAMB WESTON HOLDINGS insiders have traded $LW stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
    Here’s a breakdown of recent trading of $LW stock by insiders over the last 6 months:
    • JAN ELI B CRAPS  (Executive Chair)  purchased 50,000 shares for an estimated $2,432,330
    • GREGORY W JONES  (VP AND CONTROLLER)  sold 1,600 shares for an estimated $99,973
    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
    LAMB WESTON HOLDINGS Hedge Fund Activity
    We have seen 292 institutional investors add shares of LAMB WESTON HOLDINGS stock to their portfolio, and 281 decrease their positions in their most recent quarter.
    Here are some of the largest recent moves:
    • JPMORGAN CHASE & CO added 6,706,492 shares (+1408.7%) to their portfolio in Q4 2025, for an estimated $280,934,949
    • M&T BANK CORP added 2,828,983 shares (+45177.0%) to their portfolio in Q4 2025, for an estimated $118,506,097
    • PRICE T ROWE ASSOCIATES INC /MD/ added 2,111,874 shares (+27.4%) to their portfolio in Q4 2025, for an estimated $88,466,401
    • MILLENNIUM MANAGEMENT LLC removed 2,010,113 shares (-77.6%) from their portfolio in Q4 2025, for an estimated $84,203,633
    • FMR LLC removed 1,989,770 shares (-75.7%) from their portfolio in Q4 2025, for an estimated $83,351,465
    • BLACKROCK, INC. removed 1,941,279 shares (-13.9%) from their portfolio in Q4 2025, for an estimated $81,320,177
    • POINT72 ASSET MANAGEMENT, L.P. removed 1,802,826 shares (-99.2%) from their portfolio in Q4 2025, for an estimated $75,520,381
    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
    LAMB WESTON HOLDINGS Price Targets
    Multiple analysts have issued price targets for $LW recently. We have seen 6 analysts offer price targets for $LW in the last 6 months, with a median target of $51.5.
    Here are some recent targets:
    • Steve Powers from Deutsche Bank set a target price of $40.0 on 03/30/2026
      •  
    • Thomas Palmer from JP Morgan set a target price of $44.0 on 03/24/2026
      •  
    • Andrew Lazar from Barclays set a target price of $55.0 on 12/23/2025
      •  
    • Marc Torrente from Wells Fargo set a target price of $54.0 on 12/23/2025
      •  
    • Peter Galbo from B of A Securities set a target price of $53.0 on 12/22/2025
      •  
    • Matthew Smith from Stifel set a target price of $50.0 on 12/22/2025
      •  
    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
    Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
    
                
    
              
    
            
    
          
    
          
          
    
            
              
            
          
    
          
          
            
          
            Read Full Article
        
    
      
    
    
      
    
        
    
          
    
            Insider Sale: Vice-President of $LAES Sells 10,000 Shares
            
    
              2 hours ago | April 1, 2026 12:45 p.m. UTC
              
    
                
    
                  
    Franck Jean Buonanno, the Vice-President of $LAES, sold 10,000 shares of the company on 03-31-2026 for an estimated $23,500. We received data on the trade from a recent SEC filing. This was a sale of approximately 50.0% of their shares of this class of stock. Following this trade, they now own 10,000 shares of this class of $LAES stock.
    $LAES Insider Trading Activity
    LAES Insider Trades
    $LAES insiders have traded $LAES stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
    Here’s a breakdown of recent trading of $LAES stock by insiders over the last 6 months:
    • JOHN CHARLES O'HARA  (Chief Financial Officer) has made 0 purchases and 5 sales selling 50,000 shares for an estimated $148,312.
    • FRANCK JEAN BUONANNO  (Vice-President, Global Sales)  sold 10,000 shares for an estimated $23,500
    • NATHALIE CLAUDE ODILE VERJUS  (Company Secretary)  sold 5,000 shares for an estimated $15,129
    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
    $LAES Hedge Fund Activity
    We have seen 72 institutional investors add shares of $LAES stock to their portfolio, and 30 decrease their positions in their most recent quarter.
    Here are some of the largest recent moves:
    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
    

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
    
                
    
              
    
            
    
          
    
          
          
    
            
              
            
          
    
          
          
            
          
            Read Full Article
        
    
      
    
    
      
    
        
    
          
    
            UNIFIRST ($UNF) Releases Q2 2026 Earnings
            
    
              2 hours ago | April 1, 2026 12:30 p.m. UTC
              
    
                
    
                  
    UNIFIRST ($UNF) posted quarterly earnings results for Q2 2026 on Wednesday, April 1st. The company reported earnings of $1.25 per share, beating estimates of $1.22 by $0.03. The company also reported revenue of $622,510,000, beating estimates of $621,072,563 by $1,437,437.
    You can see Quiver Quantitative's $UNF stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
    UNIFIRST Insider Trading Activity
    UNF Insider Trades
    UNIFIRST insiders have traded $UNF stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
    Here’s a breakdown of recent trading of $UNF stock by insiders over the last 6 months:
    • DAVID MARTIN KATZ  (Executive VP, Sales/Marketing) has made 0 purchases and 3 sales selling 1,473 shares for an estimated $349,155.
    • WILLIAM MASTERS ROSS  (Executive Vice President)  sold 1,128 shares for an estimated $227,156
    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
    UNIFIRST Hedge Fund Activity
    We have seen 136 institutional investors add shares of UNIFIRST stock to their portfolio, and 188 decrease their positions in their most recent quarter.
    Here are some of the largest recent moves:
    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
    UNIFIRST Government Contracts
    We have seen $2,711,161 of award payments to $UNF over the last year.
    Here are some of the awards which we have have seen pay out the most over the last year:
    To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
    UNIFIRST Price Targets
    Multiple analysts have issued price targets for $UNF recently. We have seen 2 analysts offer price targets for $UNF in the last 6 months, with a median target of $243.0.
    Here are some recent targets:
    • Manav Patnaik from Barclays set a target price of $280.0 on 03/12/2026
      •  
    • Joshua Chan from UBS set a target price of $206.0 on 01/08/2026
      •  
    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
    Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
    
                
    
              
    
            
    
          
    
          
          
    
            
              
            
          
    
          
          
            
          
            Read Full Article
        
    
      
    
    
      
    
        
    
          
    
            SYNERGY CHC ($SNYR) Releases Q4 2025 Earnings
            
    
              2 hours ago | April 1, 2026 12:30 p.m. UTC
              
    
                
    
                  
    SYNERGY CHC ($SNYR) posted quarterly earnings results for Q4 2025 on Wednesday, April 1st. The company reported earnings of -$0.31 per share, missing estimates of $0.01 by $0.32. The company also reported revenue of $6,070,000, missing estimates of $11,046,600 by $-4,976,600.
    You can see Quiver Quantitative's $SNYR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
    SYNERGY CHC Hedge Fund Activity
    We have seen 9 institutional investors add shares of SYNERGY CHC stock to their portfolio, and 4 decrease their positions in their most recent quarter.
    Here are some of the largest recent moves:
    • SANDERS MORRIS HARRIS LLC removed 391,702 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $728,565
    • VANGUARD GROUP INC added 29,100 shares (+44.1%) to their portfolio in Q4 2025, for an estimated $54,126
    • WARBERG ASSET MANAGEMENT LLC removed 19,844 shares (-59.2%) from their portfolio in Q4 2025, for an estimated $36,909
    • DRW SECURITIES, LLC added 19,487 shares (+inf%) to their portfolio in Q4 2025, for an estimated $36,245
    • VIRTU FINANCIAL LLC removed 15,698 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $29,198
    • CITADEL ADVISORS LLC added 13,809 shares (+inf%) to their portfolio in Q4 2025, for an estimated $25,684
    • JANE STREET GROUP, LLC added 10,464 shares (+inf%) to their portfolio in Q4 2025, for an estimated $19,463
    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
    SYNERGY CHC Analyst Ratings
    Wall Street analysts have issued reports on $SNYR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
    Here are some recent analyst ratings:
    • Roth Capital issued a "Buy" rating on 11/14/2025
    To track analyst ratings and price targets for SYNERGY CHC, check out Quiver Quantitative's $SNYR forecast page.
    SYNERGY CHC Price Targets
    Multiple analysts have issued price targets for $SNYR recently. We have seen 2 analysts offer price targets for $SNYR in the last 6 months, with a median target of $6.0.
    Here are some recent targets:
    • Edward Woo from Ascendiant Capital set a target price of $5.0 on 02/02/2026
      •  
    • Sean McGowan from Roth Capital set a target price of $7.0 on 11/14/2025
      •  
    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
    Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
    
                
    
              
    
            
    
          
    
          
          
    
            
              
            
          
    
          
          
            
          
            Read Full Article
        
    
      
    
    
      
    
        
    
          
    
            $NG ($NG) Releases Q1 2026 Earnings
            
    
              2 hours ago | April 1, 2026 12:30 p.m. UTC
              
    
                
    
                  
    $NG ($NG) posted quarterly earnings results for Q1 2026 on Wednesday, April 1st. The company reported earnings of -$0.04 per share, beating estimates of -$0.05 by $0.01. The company also reported revenue of $0, equaling estimates of $0 by $0.
    You can see Quiver Quantitative's $NG stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
    $NG Insider Trading Activity
    $NG insiders have traded $NG stock on the open market 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
    Here’s a breakdown of recent trading of $NG stock by insiders over the last 6 months:
    • QUINTANILLA DANIEL MUNIZ  purchased 22,470 shares for an estimated $200,881
    • DAWN PATRICIA WHITTAKER  purchased 4,000 shares for an estimated $37,440
    • ELAINE J DORWARD-KING  sold 11 shares for an estimated $114
    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
    $NG Hedge Fund Activity
    We have seen 116 institutional investors add shares of $NG stock to their portfolio, and 81 decrease their positions in their most recent quarter.
    Here are some of the largest recent moves:
    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
    $NG Price Targets
    Multiple analysts have issued price targets for $NG recently. We have seen 4 analysts offer price targets for $NG in the last 6 months, with a median target of $13.0.
    Here are some recent targets:
    • Carey Macrury from Canaccord Genuity set a target price of $13.0 on 03/27/2026
      •  
    • Josh Wolfson from RBC Capital set a target price of $14.0 on 03/19/2026
      •  
    • Nick Giles from B. Riley Securities set a target price of $13.0 on 01/27/2026
      •  
    • Alexander Hacking from Citigroup set a target price of $12.5 on 10/15/2025
      •  
    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
    Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
    
                
    
              
    
            
    
          
    
          
          
    
            
              
            
          
    
          
          
            
          
            Read Full Article
        
    
      
    
    
      
    
        
    
          
    
            Kayne Anderson Energy Infrastructure Fund, Inc. Announces Monthly Distribution of $0.085 per Share for April 2026
            
    
              3 hours ago | April 1, 2026 12:01 p.m. UTC
              
    
                
    
                  
    Kayne Anderson Energy Infrastructure Fund announces a monthly distribution of $0.085 per share, payable April 30, 2026.
    Quiver AI Summary
    Kayne Anderson Energy Infrastructure Fund, Inc. announced a monthly distribution of $0.085 per share for April 2026, payable to common stockholders on April 30, 2026. The distribution is subject to the approval of the Board of Directors and must comply with the company's debt covenants and preferred stock terms. The company invests primarily in energy infrastructure companies and aims to provide high after-tax returns while making cash distributions. The amount of future distributions may vary based on portfolio changes and market conditions. The press release includes a caution about forward-looking statements and advises consultation with financial advisors before investing.
    Potential Positives
    • Announcement of a monthly distribution of $0.085 per share demonstrates the company's commitment to returning value to shareholders.
    • The distribution payment date of April 30, 2026, provides clarity for investors regarding cash flow.
    • Kayne Anderson Energy Infrastructure Fund's strategy of focusing on Energy Infrastructure Companies may position it well in an important sector.
    Potential Negatives
    • The payment of future distributions is contingent upon Board approval and meeting covenants on debt agreements, implying uncertainty in ongoing financial stability.
    • The distribution is fully characterized as a return of capital, which may indicate weakness in generating sufficient earnings and profits.
    • The potential variability in distribution amounts based on portfolio performance and market conditions could lead to investor uncertainty and dissatisfaction.
    FAQ
    What is the monthly distribution amount for April 2026?
    The monthly distribution amount for April 2026 is $0.085 per share.
    When will the distribution be paid to stockholders?
    The distribution will be paid to common stockholders on April 30, 2026.
    What factors affect the future distributions of Kayne Anderson?
    Future distributions are subject to Board approval, debt covenant compliance, and preferred stock terms.
    What percentage of the distribution is considered a return of capital?
    The return of capital estimate for the distribution is 50% based on anticipated earnings.
    Where can I find more information about the company's investment strategy?
    More information about the investment strategy can be found in the Company's most recent quarterly or annual report.
    Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

    $KYN Insider Trading Activity
    KYN Insider Trades
    $KYN insiders have traded $KYN stock on the open market 10 times in the past 6 months. Of those trades, 10 have been purchases and 0 have been sales.
    Here’s a breakdown of recent trading of $KYN stock by insiders over the last 6 months:
    • INVESTMENT MANAGEMENT, LLC METLIFE  has made 2 purchases buying 25,000,000 shares for an estimated $10,000,000 and 0 sales.
    • JAMES C BAKER  (President) has made 4 purchases buying 100,000 shares for an estimated $1,297,892 and 0 sales.
    • MICHAEL N MEARS  purchased 10,000 shares for an estimated $122,365
    • HARRISON JAMES LITTLE  (Executive Vice President)  purchased 5,000 shares for an estimated $70,575
    • HOLLI C. LADHANI  purchased 3,600 shares for an estimated $50,004
    • AUSTIN COLBY PARKER  (CFO and Treasurer)  purchased 2,500 shares for an estimated $35,800
    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
    $KYN Hedge Fund Activity
    We have seen 105 institutional investors add shares of $KYN stock to their portfolio, and 85 decrease their positions in their most recent quarter.
    Here are some of the largest recent moves:
    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
    Full Release
    
 
    
  HOUSTON, April  01, 2026  (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) announced today a monthly distribution of $0.085 per share for April 2026. This distribution is payable to common stockholders on April 30, 2026 (as outlined in the table below).
 
    
 
    
  The Company declares and pays distributions monthly. Payment of future distributions is subject to the approval of the Company’s Board of Directors, as well as meeting the covenants on the Company’s debt agreements and the terms of its preferred stock.
 
    
 
    
  
    
   
    
     Record Date / Ex-Date
    
   
   
    
     Payment Date
    
   
   
    
     Distribution Amount
    
   
   
    
     Return of Capital
    
    
    
    
     Estimate
    
       		
  
    
  
    
   
    4/15/26
   
   
    4/30/26
   
   
    $0.085
   
   
    50%
    
     (
    
    
     1
    
    
     )
    
   
  
    
 
    
 
    
  
    
  (1) This estimate is based on the Company’s anticipated earnings and profits. The final determination of the tax character of distributions will not be determinable until after the end of fiscal 2026 and may differ substantially from this preliminary information.
  
    
 
    
 
    
  
   Kayne Anderson Energy Infrastructure Fund, Inc. (NYSE: KYN) is a non-diversified, closed-end management investment company registered under the Investment Company Act of 1940, as amended, whose common stock is traded on the NYSE. The Company’s investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to stockholders. KYN intends to achieve this objective by investing at least 80% of its total assets in securities of Energy Infrastructure Companies. See Glossary of Key Terms in the Company’s most recent quarterly or annual report for a description of these investment categories and the meaning of capitalized terms.
  
 
    
 
    
  
   The Company pays cash distributions to common stockholders at a rate that may be adjusted from time to time. Distribution amounts are not guaranteed and may vary depending on a number of factors, including changes in portfolio holdings and market conditions.
  
 
    
 
    
  
   This press release shall not constitute an offer to sell or a solicitation to buy, nor shall there be any sale of any securities in any jurisdiction in which such offer or sale is not permitted. Nothing contained in this press release is intended to recommend any investment policy or investment strategy or consider any investor’s specific objectives or circumstances. Before investing, please consult with your investment, tax, or legal adviser regarding your individual circumstances.
  
 
    
 
    
  
   CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This communication contains statements reflecting assumptions, expectations, projections, intentions, or beliefs about future events. These and other statements not relating strictly to historical or current facts constitute forward-looking statements as defined under the U.S. federal securities laws. Forward-looking statements involve a variety of risks and uncertainties. These risks include but are not limited to changes in economic and political conditions; regulatory and legal changes; energy industry risk; leverage risk; valuation risk; interest rate risk; tax risk; and other risks discussed in detail in the Company’s filings with the SEC, available at
  
  
   
    www.kaynefunds.com
   
  
  
   or
  
  
   
    www.sec.gov
   
  
  
   . Actual events could differ materially from these statements or our present expectations or projections. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. Kayne Anderson undertakes no obligation to publicly update or revise any forward-looking statements made herein. There is no assurance that the Company’s investment objectives will be attained.
  
 
    
 
    
  Contact investor relations at 877-657-3863 or
  
   [email protected]
  
  .
 
    
 
    

    

    
                
    
              
    
            
    
          
    
          
          
    
            
              
            
          
    
          
          
            
          
            Read Full Article
        
    
      
    
    
  
    

  
    
    Back to Top